Compounds > prednisone
Page last updated: 2024-11-07

prednisone and Aortic Arteritis, Giant Cell

prednisone has been researched along with Aortic Arteritis, Giant Cell in 525 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research Excerpts

ExcerptRelevanceReference
"To measure serial interleukin (IL)-6 levels in newly diagnosed patients with giant cell arteritis (GCA), treated in a randomized controlled trial of modified-release prednisone (MR) vs immediate-release prednisolone (IR) used in a tapering regimen conforming to British Society for Rheumatology GCA guidelines."9.30Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis. ( Aung, T; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Miler, E; Schofield, P; Stapleton, PP; Wilson, L, 2019)
"A feasibility study to assess efficacy and safety of modified release (MR) prednisone (Lodotra™) compared to immediate release (IR) prednisolone in patients with newly diagnosed giant cell arteritis (GCA)."9.27A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis. ( Achilleos, K; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Maw, WW; Merinopoulos, D; Raine, C; Schofield, P; Stapleton, PP, 2018)
"To compare bone mass loss due to deflazacort versus prednisone in longterm treatment of patients with giant cell arteritis (GCA) in a randomized double blind comparative trial."9.09Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. ( Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM, 2001)
"To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)."9.08Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? ( Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ, 1996)
"To determine the effect of methotrexate (MTX) on relapse risk and glucocorticoid (GC) use in a large single-institution cohort of patients with giant cell arteritis (GCA)."7.91Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study. ( Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K, 2019)
" We studied two patients with giant cell arteritis in whom rifampin caused nonresponsiveness to prednisone treatment."7.69Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment. ( Becq-Giraudon, B; Bouquet, S; Carrie, F; Delon, A; Roblot, F; Roblot, P, 1994)
"The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result."7.67[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984)
"Three patients (one with polymyalgia rheumatica with jaw claudication and two with biopsy-proven giant cell arteritis) were initially treated using prednisone (40-60 mg daily)."7.67Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. ( Krall, PL; Mazanec, DJ; Wilke, WS, 1989)
"The transcapillary escape rate of albumin was measured in 27 consecutive patients with inflammatory rheumatic diseases before and after 1 and 7 days of prednisone treatment in doses of 45 mg/day."7.66Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases. ( Hansen, TM; Junker, P; Lorenzen, I; Manthorpe, R; Utne, HE, 1979)
"Mavrilimumab plus 26 weeks of prednisone was superior to placebo plus 26 weeks of prednisone for time to flare by week 26 and sustained remission in patients with giant cell arteritis."5.51Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. ( Blockmans, D; Brouwer, E; Cid, MC; Dagna, L; Dasgupta, B; Hellmich, B; Molloy, E; Paolini, JF; Pupim, L; Salvarani, C; Samant, M; Trapnell, BC; Unizony, SH; Warrington, KJ; Wicks, I; Zhou, T, 2022)
"Among patients with active polymyalgia rheumatica despite prednisone therapy, tocilizumab, compared with placebo, resulted in a significantly greater percentage of patients with a CRP PMR-AS less than 10 with reduced prednisone requirements at week 24."5.51Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial. ( Carvajal-Alegria, G; Chary-Valckenaere, I; Chiche, L; Cornec, D; Dernis, E; Dervieux, B; Devauchelle-Pensec, V; Direz, G; Fautrel, BJ; Felten, R; Gottenberg, JE; Guellec, D; Hilliquin, P; Le Henaff, C; Marhadour, T; Nowak, E; Perdriger, A; Richez, C; Saraux, A; Toussirot, E; Truchetet, ME; Wendling, D, 2022)
"To measure serial interleukin (IL)-6 levels in newly diagnosed patients with giant cell arteritis (GCA), treated in a randomized controlled trial of modified-release prednisone (MR) vs immediate-release prednisolone (IR) used in a tapering regimen conforming to British Society for Rheumatology GCA guidelines."5.30Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis. ( Aung, T; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Miler, E; Schofield, P; Stapleton, PP; Wilson, L, 2019)
"Exploratory analyses of SF-36 PCS and MCS and domain scores, PtGA and FACIT-Fatigue were performed in patients treated with weekly subcutaneous TCZ 162 mg plus 26-week prednisone taper (TCZ-QW + Pred-26) or placebo plus 26-week or 52-week prednisone tapers (PBO + Pred-26 or PBO + Pred-52)."5.30Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial. ( Collinson, N; Dimonaco, S; Klearman, M; Stone, JH; Strand, V; Tuckwell, K, 2019)
"A feasibility study to assess efficacy and safety of modified release (MR) prednisone (Lodotra™) compared to immediate release (IR) prednisolone in patients with newly diagnosed giant cell arteritis (GCA)."5.27A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis. ( Achilleos, K; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Maw, WW; Merinopoulos, D; Raine, C; Schofield, P; Stapleton, PP, 2018)
"To compare bone mass loss due to deflazacort versus prednisone in longterm treatment of patients with giant cell arteritis (GCA) in a randomized double blind comparative trial."5.09Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. ( Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM, 2001)
"To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)."5.08Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? ( Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ, 1996)
"The objective is to investigate whether initial therapy with intravenous methylprednisolone pulses (ivMTP) or oral glucocorticoid (OG) influences the relapse rate in giant cell arteritis (GCA) patients."4.31Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study. ( Álvaro-Gracia, JM; Anzola-Alfaro, AM; Castrejón, I; López, K; Martínez-Barrio, J; Molina-Collada, J; Rivera, J; Serrano-Benavente, B; Trives-Folguera, L, 2023)
"The case of a 75-year-old woman diagnosed with polymyalgia rheumatica (PMR), treated with low doses of prednisone, and with clinical and analytical remission is reported."4.12Giant cell arteritis with spontaneous remission. ( Alonso-Valdivielso, JL; Álvarez-Lario, B; Colazo-Burlato, M; Lorenzo-Martín, JA; Macarrón-Vicente, JL, 2022)
" There were no perioperative or postoperative complications in the 15 eyes that underwent cataract surgery with varying doses of prednisone at the time of surgery (1 to 25 mg daily prednisone ± 10 to 25 mg weekly methotrexate; median prednisone dose of 10."4.02Timing of cataract surgery in patients with giant cell arteritis. ( Chacko, JG; Fong, JW, 2021)
"This study aimed to identify the incidence of ophthalmic complications of giant cell arteritis (GCA) among subjects with negative temporal artery biopsy (TAB) and to determine if duration of prednisone exposure relative to GCA diagnosis was associated with ophthalmic complications in TAB-negative subjects."4.02The U.S. Veterans Health Administration national giant cell arteritis (GCA) database cohort: incident ophthalmic complications in biopsy-negative GCA patients. ( Chung, SH; Morcos, MB; Ng, B; Pollock, PS, 2021)
"To determine the effect of methotrexate (MTX) on relapse risk and glucocorticoid (GC) use in a large single-institution cohort of patients with giant cell arteritis (GCA)."3.91Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study. ( Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K, 2019)
"An 82-year-old woman with polymyalgia rheumatica (PMR) on prednisone 7 mg daily was admitted to an acute stroke unit with a right homonymous hemianopia, a left posterior cerebral artery occlusion and occipital lobe infarct."3.85Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale. ( Gutteridge, DH; Mastaglia, FL, 2017)
" She had been taking prednisone 60-40 mg daily for 6 weeks for suspected giant cell arteritis, along with six other regular medications, and had recently finished a course of antibiotics."3.81No medicine is sometimes the best medicine. ( Wallis, KA, 2015)
"Lipodystrophy and neuropsychiatric disorders are common adverse events of long-term prednisone therapy and are particularly distressing for the patients concerned."3.74Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. ( Cabane, J; Fardet, L; Flahault, A; Généreau, T; Kettaneh, A; Lebbé, C; Tiev, KP; Tolédano, C, 2007)
" However, adjusting for age, sex, and classic atherosclerosis risk factors, no significant correlation between carotid IMT and the routine laboratory markers of inflammation assessed at the time of disease diagnosis, disease duration, or cumulative prednisone dose was found."3.74Atherosclerosis in patients with biopsy-proven giant cell arteritis. ( Gonzalez-Gay, MA; Gonzalez-Juanatey, C; Llorca, J; Lopez-Diaz, MJ; Martin, J, 2007)
"A patient with arteriosclerosis, diabetes mellitus, and giant cell arteritis (GCA) treated continuously with low-dose prednisone developed anterior ischemic optic neuropathy (AION) at 5 and 13 months after clinical diagnosis of GCA."3.72Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. ( Flint, A; Keoleian, G; Kim, N; Trobe, JD, 2003)
" In the year before the current admission she developed myalgias and was treated for polymyalgia rheumatica with low-dose prednisone."3.70[Clinical thinking and decision making in the practice. A patient with fever of unknown origin]. ( de Meijer, PH; Meinders, AE; Schippers, EF, 1998)
"Despite receiving high-dose intravenous methylprednisolone and oral prednisone for biopsy-proven giant cell arteritis that presented as a severe anterior ischemic optic neuropathy in the right eye, a patient developed progressive ocular ischemia in that eye as well as an ocular ischemic syndrome in the fellow eye."3.70Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. ( Girkin, CA; Hellmann, DB; Hwang, JM; Lai, JC; Miller, NR; Perry, JD, 1999)
" Due to the presumed diagnosis of giant cell arteritis (GCA), the patient was treated with prednisone (60 mg daily), with immediate improvement in his symptoms."3.69Occult subacute thyroiditis mimicking classic giant cell arteritis. ( Kramer, N; Rosenstein, ED, 1994)
" We studied two patients with giant cell arteritis in whom rifampin caused nonresponsiveness to prednisone treatment."3.69Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment. ( Becq-Giraudon, B; Bouquet, S; Carrie, F; Delon, A; Roblot, F; Roblot, P, 1994)
" We report a case of PCP occurring in a patient with giant cell arteritis who was receiving high dose prednisone."3.68Pneumocystis carinii pneumonia following corticosteroid therapy for giant cell arteritis. ( Crayton, HE; Sundstrom, WR, 1991)
"The basal and calcium-stimulated calcitonin response was measured in 10 patients with giant cell arteritis before and 1, 3 and 6 wk after the start of daily treatment with 60 mg of prednisone."3.68Change of serum calcitonin in patients receiving glucocorticoids: an acute phase study. ( Hackeng, WH; Mulder, H; Siersema-Smallegange, M; vd Lely, AJ, 1990)
"The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result."3.67[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984)
"Three patients (one with polymyalgia rheumatica with jaw claudication and two with biopsy-proven giant cell arteritis) were initially treated using prednisone (40-60 mg daily)."3.67Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. ( Krall, PL; Mazanec, DJ; Wilke, WS, 1989)
"The transcapillary escape rate of albumin was measured in 27 consecutive patients with inflammatory rheumatic diseases before and after 1 and 7 days of prednisone treatment in doses of 45 mg/day."3.66Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases. ( Hansen, TM; Junker, P; Lorenzen, I; Manthorpe, R; Utne, HE, 1979)
"A case of giant cell arteritis (temporal arteritis) is presented in a 73-year-old male patient in whom lasting reduction of vision developed during high-level prednisone treatment (60 mg daily) at a time when clinical improvement in other respects had appeared."3.66Temporal arteritis--progressive affection of vision during high-level corticosteroid therapy. A case report. ( Hugod, C; Scheibel, M, 1979)
"A 70-year-old woman presenting with typical polymyalgia rheumatica (PMR) and a normal temporal artery biopsy appeared to respond completely to low-dose prednisone therapy."3.65Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica. ( Bartholomew, LE; Mika, P; Rynes, RI, 1977)
" However, its long-term benefits in new-onset vs relapsing disease are uncertain, and the value of weekly vs every-other-week dosing has not been evaluated."3.11New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension. ( Aringer, M; Bao, M; Blockmans, D; Brouwer, E; Cid, MC; Dasgupta, B; Rech, J; Salvarani, C; Spiera, R; Spotswood, H; Stone, JH; Unizony, SH, 2022)
"Relapse was defined as the recurrence of GCA symptoms requiring treatment intensification."3.01Ustekinumab for the Treatment of Giant Cell Arteritis. ( Fernandes, AD; Matza, MA; Stone, JH; Unizony, SH, 2021)
"Patients with GCA were randomly assigned to receive double-blind dosing with either subcutaneous tocilizumab (TCZ) 162 mg weekly plus 26-week prednisone taper (TCZ-QW + Pred-26), every-other-week TCZ plus 26-week prednisone taper (TCZ-Q2W + Pred-26), placebo plus 26-week prednisone taper (PBO + Pred-26), or placebo plus 52-week prednisone taper (PBO + Pred-52)."2.90Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab. ( Aringer, M; Blockmans, D; Brouwer, E; Cid, MC; Collinson, N; Dasgupta, B; Dimonaco, S; Klearman, M; Rech, J; Salvarani, C; Schett, G; Schulze-Koops, H; Spiera, R; Stone, JH; Tuckwell, K; Unizony, SH, 2019)
"Prednisone was started at 0."2.87Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. ( Audia, S; Besancenot, JF; Bienvenu, B; Binquet, C; Bonnotte, B; Charles, P; Devilliers, H; Fauchais, AL; Guillevin, L; Liozon, E; Loffroy, R; Ly, KH; Mariette, X; Maurier, F; Samson, M; Seror, R; Terrier, B, 2018)
" Dosing of prednisone and safety were also assessed."2.84Trial of Tocilizumab in Giant-Cell Arteritis. ( Aringer, M; Blockmans, D; Brouwer, E; Cid, MC; Collinson, N; Dasgupta, B; Dimonaco, S; Klearman, M; Rech, J; Salvarani, C; Schett, G; Schulze-Koops, H; Spiera, R; Stone, JH; Tuckwell, K; Unizony, SH, 2017)
"Anterior ischemic optic neuropathy was the dominant mechanism of vision loss."2.82Vision loss in giant cell arteritis: case-based review. ( Aligianni, SI; Daoussis, D; Kokloni, IN; Makri, O, 2022)
" Secondary end points were time to first relapse, biomarkers, cumulative glucocorticosteroid dose, and the number of patients who remained relapse-free while the glucocorticosteroid dosage was tapered to 10 mg/d."2.73Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. ( Cid, MC; Hoffman, GS; Merkel, PA; Rahman, MU; Rendt-Zagar, KE; Salvarani, C; Stone, JH; Visvanathan, S; Weyand, CM; Xu, W, 2007)
" Adjunctive methotrexate may reduce cumulative glucocorticoid dosage by 20% to 44% and relapses by 36% to 54% in both PMR and GCA."2.53Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. ( Buttgereit, F; Dasgupta, B; Dejaco, C; Matteson, EL, 2016)
" The choice of initial prednisone dosage (from 0."2.49[Treatment of giant cell arteritis]. ( Bienvenu, B; Pugnet, G; Sailler, L, 2013)
"Venous thrombosis is rarely found at the onset of temporal arteritis, particularly when venous symptoms precede arterial involvement."2.46[Superficial cranial venous thromboses preceding the diagnosis of giant cell arteritis]. ( Charlanne, H; Cousin, M; de Coppet, H; Hachulla, E; Hatron, PY; Lambert, M; Lamotte, C; Launay, D; Maillard-Lefebvre, H; Morell-Dubois, S, 2010)
"Clinicians who treat patients with giant cell arteritis (GCA) face many unresolved challenges."2.44Five clinical conundrums in the management of giant cell arteritis. ( Cid, MC; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Lozano, E, 2007)
"Giant cell arteritis was suspected on clinical and laboratory grounds and was documented on temporal artery biopsy."2.43[Horton's disease revealed by brachial C5 plexopathy]. ( Blaise, S; Liozon, E; Nadalon, S; Vidal, E, 2005)
"If untreated, polymyalgia rheumatica may result in significant disability."2.43Polymyalgia rheumatica and giant cell arteritis. ( Gilliland, W; Unwin, B; Williams, CM, 2006)
"Giant cell arteritis or temporal arteritis is a chronic vasculitis of large and medium-size vessels."2.42Giant cell arteritis: strategies in diagnosis and treatment. ( Nordborg, C; Nordborg, E, 2004)
"When unrecognized and therefore untreated, vasculitis of the nervous system leads to pervasive injury and disability making this a disorder of paramount importance to all clinicians."2.42Vasculitis of the nervous system. ( Younger, DS, 2004)
"There were no recurrences at discontinuation of the treatment."2.39[Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients]. ( Coustals, P; Dromer, C; Fournié, B; Le Guennec, P; Marc, V; Sixou, L, 1994)
" We describe 3 such patients, and our experience in tapering their steroid dosage with the use of dapsone or methotrexate."2.39Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients. ( Nesher, G; Sonnenblick, M, 1994)
"Out of 47 patients with amaurosis, 23 remained with permanent unit or bilateral blindness."2.39[Giant cell arteritis. A study of 191 patients]. ( Armona, J; Blanco, R; Fernández-Sueiro, JL; Figueroa, M; González-Gay, MA; Martínez-Taboada, V; Rodríguez-Valverde, V, 1995)
"Pneumocystis carinii pneumonia is most often seen in severely immunosuppressed patients related to the acquired immunodeficiency syndrome or treatment of malignancies with potent cytotoxic agents."2.39Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia. ( Gibbons, RB; Krebs, S, 1996)
"We report a case of biopsy-proven temporal arteritis and polymyalgia rheumatica with improved clinical symptoms with steroid treatment but with subsequent renal failure while on steroids."2.38Renal failure in temporal arteritis. ( Barril, G; Bernis, C; Canton, CG; García, A; Osorio, C; Paraiso, V; Rincón, B; Traver, JA, 1992)
"Giant cell arteritis is becoming recognized as one of the most common forms of vasculitis."2.38Giant cell (temporal) arteritis. ( Hunder, GG, 1990)
"9) and higher baseline prednisone dosage (RR = 1."1.91Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica. ( Bartoloni, E; Bogdanos, D; Bursi, R; Cafaro, G; Fiumicelli, E; Gerli, R; Perricone, C; Riccucci, I, 2023)
"Glucocorticoids are associated with serious side effects related to dosing and time of use."1.91Development of a web tool to calculate the cumulative dose of glucocorticoids. ( Díaz-González, F; Guerra-Rodríguez, M; Loricera, J; Montero-Pastor, N; Moriano, C; Sánchez-Alonso, F; Sánchez-Costa, JT, 2023)
"Prednisone was discontinued in 76."1.91Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis. ( Dagincourt, N; Han, J; Matza, MA; Mohan, SV; Pavlov, A; Stone, JH; Unizony, SH, 2023)
"Older age and higher frailty score were significantly associated with increased risk for serious infection."1.72Giant cell arteritis treatment patterns and rates of serious infections. ( Jin, Y; Kim, SC; Lee, H; Pethoe-Schramm, A; Tedeschi, SK; Vine, S; Yau, V, 2022)
"Dermatomyositis is a rare, idiopathic inflammatory myopathy characterized by erythematous skin lesions and inflammation of skeletal muscles."1.56Autoimmune Conditions: Polymyalgia Rheumatica and Dermatomyositis. ( Ghetu, MV, 2020)
"Giant cell arteritis is a common systemic vasculitis affecting the elderly, with maximum prevalence in the 7th decade of age, targeting aortic derived medium and large vessels of the neck and head."1.51Will imaging change the diagnosis and management of giant cell arteritis? ( Badea, C; Băicuș, C; Chiriac, A, 2019)
"Giant cell arteritis is a large-vessels vasculitis, which treatment consists in a slowly-tappered steroid-therapy."1.48[Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients]. ( Arnaud, E; Broner, J, 2018)
"Relapse was defined as either new disease activity after a period of remission or worsening disease activity."1.42Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. ( Carette, S; Cuthbertson, D; Hoffman, GS; Kermani, TA; Khalidi, NA; Koening, CL; Langford, CA; Maksimowicz-McKinnon, K; McAlear, CA; Merkel, PA; Monach, PA; Seo, P; Warrington, KJ; Ytterberg, SR, 2015)
"Osteoporosis was more common in patients with relapses compared to those without (65% vs 32%, p = 0."1.40Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. ( Alba, MA; Butjosa, M; Cid, MC; Corbera-Bellalta, M; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Planas-Rigol, E; Prieto-González, S; Tavera-Bahillo, I, 2014)
"Esophagitis is the second most common gastrointestinal manifestation of CMV infection after colitis."1.39Cytomegalovirus esophagitis precipitated with immunosuppression in elderly giant cell arteritis patients. ( Akın, S; Bahat, G; Erten, N; Karan, MA; Saka, B; Tufan, F, 2013)
" Adequate glucocorticoid dosing and gradual tapering are key to treatment success."1.39Polymyalgia rheumatica and giant cell arteritis: how best to approach these related diseases. ( Freeman, AC; Rapoport, RJ, 2013)
"Giant cell arteritis is rarely recognized in Latin America."1.38Giant cell arteritis in Mexican patients. ( Alba, MA; Flores-Suárez, LF; Mena-Madrazo, JA; Reyes, E, 2012)
" All patients were taking prednisone (the median dosage 50 mg/day [range 30-80]) when diagnosed as having PCP."1.37Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series. ( Kermani, TA; Warrington, KJ; Ytterberg, SR, 2011)
" This dosage is diminished very gradually according to a uniform treatment schedule during a period of 3 months, thereafter depending on the clinical course."1.36[Dutch College of General Practitioner's practice guideline on polymyalgia rheumatica and temporal arteritis]. ( Dubbeld, P; Eizenga, WH; Geijer, RM; Goudswaard, AN; Hakvoort, L, 2010)
"Giant cell arteritis was suspected, and early treatment with corticosteroids led to complete resolution and no need for further intervention."1.35Acute bilateral tongue necrosis--a case report. ( Saeed, NR; Sainuddin, S, 2008)
"Temporal arteritis (TA) may offer major complications, whilst high dosage of prednisone may result in serious side effects."1.34Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis. Identification of a relatively benign subgroup. ( Haanen, HC; Seldenrijk, CA; ter Borg, EJ, 2007)
"Giant cell arteritis is a systemic vasculitis that affects large- and medium sized arteries."1.33[Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report]. ( Budrowski, R; Mariak, Z; Obuchowska, I, 2006)
"All patients were treated with GCs and responded rapidly (median initial dosage 60 mg prednisone/day)."1.32Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. ( Gabriel, SE; Hunder, GG; O'Fallon, WM; Orces, C; Proven, A, 2003)
"Hypogonadism has traditionally been classified as either hypogonadotropic or hypergonadotropic based on serum gonadotropin levels."1.32Acute stress masking the biochemical phenotype of partial androgen insensitivity syndrome in a patient with a novel mutation in the androgen receptor. ( Crowley, WF; Dwyer, AA; Hayes, FJ; McPhaul, MJ; Pitteloud, N; Villegas, J, 2004)
"Horizontal nystagmus was found in seven GCA patients who developed nystagmus in the head hanging position test compared with none in the controls (P =."1.32Giant cell arteritis: a new association with benign paroxysmal positional vertigo. ( Amor-Dorado, JC; Costa-Ribas, C; Garcia-Porrua, C; Gonzalez-Gay, MA; Llorca, J, 2004)
"Giant cell arteritis was suspected clinically."1.32Positron emission tomography in the diagnosis of giant cell arteritis. ( Espinola, D; Fletcher, TM, 2004)
"This case highlights for temporal arteritis the importance of accurate and timely diagnosis as well as the need for prompt therapy with systemic steroids in order to avoid major complications, namely loss of vision."1.31Temporal arteritis presenting with scalp ulceration. ( Fernandes, B; Figueiredo, A; Freitas, J; Monteiro, C; Reis, I; Tellechea, O, 2002)
"Giant cell arteritis is a T-cell dependent auto-immune vasculitis that involves a T-helper l (Th1) cell response."1.31[Horton's disease and hypereosinophilic syndrome: a non-fortuitous association]. ( Gissot, V; Jauberteau, MO; Liozon, E; Loustaud, V; Soria, P; Vidal, E, 2000)
" In order to obtain a corticosteroid-sparing effect, new studies are necessary to evaluate a reduced initial dosage of corticosteroids."1.31[Horton's disease in elderly patients aged over 75: clinical course, complications of corticotherapy. Comparative study of 164 patients. Towards a reduced initial dose]. ( Barrier, JH; Chevalet, P; de Wazières, B; Duhamel, E; el Kouri, D; Glémarec, J; Hamidou, M; Jégo, P; Maugars, Y; Planchon, B; Rodat, O, 2001)
"One hundred seventy-four patients with temporal arteritis (147 biopsy proven) were prospectively observed for the development of permanent visual loss."1.31Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. ( Herrmann, F; Liozon, E; Loustaud, V; Ly, K; Robert, PY; Soria, P; Vidal, E, 2001)
"Prednisone was prescribed in 148 patients (mean dose 23 +/- 14 mg) for a mean time of 28 +/- 29 mo."1.30Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. ( Bahlas, S; Davis, P; Ramos-Remus, C, 1998)
"To describe a patient with alternating amaurosis fugax and the importance of this condition in diagnosing temporal arteritis."1.30Alternating amaurosis fugax and temporal arteritis. ( Finelli, PF, 1997)
"Scalp necrosis is a valuable sign that frequently is misdiagnosed until visual loss occurs."1.30Scalp necrosis with giant cell arteritis. ( Cornblath, WT; Dudenhoefer, EJ; Schatz, MP, 1998)
"Relapses were frequent in both isolated PMR and PMR associated with GCA."1.30The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. ( Dababneh, A; García-Porrúa, C; González-Gay, MA; Hajeer, A; Ollier, WE; Vázquez-Caruncho, M, 1999)
" The lung cancer (without lymph node metastases) was resected, and the temporal arteritis treated with prednisone in the standard dosage regimen."1.29Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. ( Lie, JT, 1995)
"Temporal arteritis is a systemic necrotizing vasculitis for which the only effective treatment is systemic corticosteroids."1.29Invasive aspergillosis. A complication of treatment of temporal arteritis. ( Wiggins, RE, 1995)
"This is the first description of temporal arteritis, polymyalgia and aortic dissection in siblings."1.29[Giant cell arteritis and aortic dissection in 2 siblings]. ( Salomon, F; Thurnheer, R, 1993)
" The close correlation of plasma IL-6 concentrations with clinical symptoms suggests a direct contribution of this cytokine to the disease manifestations and presents the possibility that monitoring IL-6 levels would be useful in making decisions on adjustment of corticosteroid dosage in individual patients."1.29Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. ( Fulbright, JW; Goronzy, JJ; Hunder, GG; Roche, NE; Wagner, AD; Weyand, CM, 1993)
"We report a case of Temporal Arteritis, carrier of IgG anticardiolipin antibodies, who presented seronegative polyarthritis with AR criteria after 7 months."1.29[Acute ischemia of the lower limb in a patient with temporal arteritis and rheumatoid arthritis, carrier of anticardiolipin antibodies]. ( Fernández Domínguez, L; Jiménez, JL; López Barros, G; Margusino Framiñán, C; Rodríguez Gómez, M, 1995)
"The primary treatment of temporal arteritis is medical, and surgery should be reserved for severe specific disabling symptoms that have failed medical therapy."1.29Temporal arteritis: diagnostic and therapeutic considerations. ( AbuRrahma, AF; Thaxton, L, 1996)
"Giant cell arteritis is usually easy to recognize, easy to treat, and satisfying to manage."1.29Giant cell arteritis: diagnosis and management. ( Bais, R; Kachroo, A; Panush, RS; Tello, C, 1996)
"Biopsy is essential in the diagnosis of temporal arteritis."1.29In-office temporal artery biopsy. ( Hofmann, RJ, 1995)
"Giant cell arteritis is a common cause of severe visual loss in older individuals."1.29Cotton-wool spots and the early diagnosis of giant cell arteritis. ( Barney, NP; Blumenkranz, MS; Boone, DE; Dieckert, JP; Folk, JC; Grand, MG; Melberg, NS; Stransky, TJ, 1995)
" Also this result differs from what most authors have observed: they maintain that Horton's arteritis has become rather resistant to the cortisone therapy and required high dosage for a very long time."1.28[Horton's bitemporal arteritis. A case report]. ( Carmenini, G; Di Maio, F; Martusciello, S; Meloni, F; Nicoletti, M; Scioli, A, 1992)
" Three months previously (having symptoms of polymyalgia rheumatica) she had started treatment with a low dosage of prednison."1.28[Temporal arteritis without histological changes]. ( Bomholt, C; Dietrichson, O; Prause, JU, 1992)
"These include temporal arteritis and Takayasu's arteritis."1.28Diagnosing giant cell temporal arteritis. ( Aburahma, AF; Witsberger, TA, 1992)
"Headache is the predominant symptom with diplopia usually appearing shortly after."1.28Temporal arteritis. ( Attanasio, R; Austin, DG, 1990)
"We describe 10 female patients with temporal arteritis (TA) and/or polymyalgia rheumatica (PMR) who presented with upper-extremity ischemia."1.28Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. ( Bachet, P; Du Colombier, PB; Dumontet, CM; Ninet, JP; Pasquier, JH; Stewart, MD, 1990)
"Giant cell arteritis is an ophthalmic emergency because of imminent danger of bilateral total blindness, which is almost always preventable if the disease is quickly identified and treated urgently and aggressively."1.28Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management. ( Hayreh, SS, 1990)
"Prednisone has to be continued over a large period of time creating adverse effects in elderly people unless minimal doses are used."1.28[Polymyalgia rheumatica and temporal arteritis. Observations on prognosis and treatment]. ( Auquier, L; Paolaggi, JB, 1990)
"Although temporal arteritis (TA) is a common vasculitis, mental status changes and higher cortical dysfunction have received limited attention in the literature."1.28Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly. ( Davis, TE; Pascuzzi, RM; Roos, KL, 1989)
"Polymyalgia rheumatica is a relatively common syndrome of older patients, mostly white, manifested by aching and morning stiffness of the pelvic and shoulder girdles and accompanied by a rapid erythrocyte sedimentation rate."1.27Polymyalgia rheumatica and giant cell arteritis. ( Healey, LA; Wilske, KR, 1984)
"In addition to cranial arteritis, the three other variants of giant cell arteritis may also lead to neurological symptoms: polymyalgia rheumatica, occult giant cell arteritis, and inflammatory aortic arch syndrome of elderly persons."1.27Giant cell arteritis and its variants. ( Gerber, NJ, 1984)
"Thirty-five cases of cranial arteritis in an Australian population have been analysed."1.27Cranial arteritis. A twenty-year review of cases. ( Koorey, DJ, 1984)
"A patient who presented with temporal arteritis was followed using pattern visual evoked potentials (VEPs)."1.27Visual evoked potentials as an aid in the diagnosis and treatment of temporal arteritis. ( Beckman, H; Hamburger, HA; Thompson, R, 1984)
"In patients with suspected temporal arteritis, numerous step sections of a long segment of temporal artery should be examined; if the results are normal, the contralateral temporal artery should be studied."1.27Bilateral blindness in temporal arteritis with skip areas. ( Brownstein, S; Codère, F; Nicolle, DA, 1983)
"The authors report two cases of Horton's disease and one case of rhizomelic pseudopolyarthritis treated initially with delta-cortisone with a very rapid favourable result."1.27[Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis]. ( Doury, P; Eulry, F; Masson, C; Maurel, C; Pattin, S; Tabaraud, F, 1983)
" Nineteen patients had ocular manifestations of giant cell arteritis always from the onset, except for a fall in visual acuity; 26 relapses were observed in 18 patients, either during reduction of steroid dosage (21 cases) or after withdrawal (5 cases)."1.27[Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. ( Alcalay, M; Becq-Giraudon, B; Boissonnot, L; Bontoux, D; Gil, R; Gouet, D; Le Berre, D; Lefevre, JP; Maréchaud, R; Risse, JF, 1986)
"By considering temporal arteritis, it is possible that blindness was avoided."1.27Bilateral sixth nerve pareses with temporal arteritis and diabetes. ( Jay, WM; Nazarian, SM, 1986)
"Twenty-four patients with biopsy proven temporal arteritis were followed for 7 years and the effect and duration of corticosteroid treatment was evaluated."1.27Prolonged corticosteroid treatment in the management of temporal arteritis. ( Friedman, B; Friedman, G, 1988)
"In 29 patients, biopsy revealed temporal arteritis (TA)."1.27Temporal arteritis: clinical aids to diagnosis. ( Fernandez-Herlihy, L, 1988)
"The diagnosis of temporal arteritis was verified by temporal biopsy."1.27Sudden deafness in a patient with temporal arteritis. ( Brook, JG; Levy, Y; Wolfovitz, E, 1987)
"Giant cell arteritis was suspected because of a markedly elevated erythrocyte sedimentation rate and confirmed by temporal artery biopsy."1.27Giant cell arteritis causes recurrent posterior circulation transient ischemic attacks which respond to corticosteroid. ( Lipton, RB; Mehler, MF; Rosenbaum, D, 1987)
"Visual loss in temporal arteritis is usually sudden and irreversible."1.27Gradual loss and recovery of vision in temporal arteritis. ( Lipton, RB; Solomon, S; Wertenbaker, C, 1985)
" Reduction of the steroid dosage was followed by regression of the tumor."1.26Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis. ( Fam, AG; Leung, F; Osoba, D, 1981)
"After steroid treatment, the polymyalgia rheumatica and dementia rapidly resolved and the CT scan and EEG became normal."1.26Polymyalgia rheumatica with diffuse cerebral disease responding rapidly to steroid therapy. ( Bates, D; Nightingale, S; Venables, GS, 1982)
"The presence of microangiopathic hemolytic anemia is consistent with the concept that erythrocyte fragmentation resulted from contract with intravascular fibrin."1.26Giant cell arteritis and microangiopathic hemolytic anemia. ( Echikson, AB; Zauber, NP, 1982)
"When temporal arteritis is suspected yet presentation is atypical, careful consideration should be given to ENT and neurologic examination, and even psychiatric evaluation."1.26Overdiagnosis of temporal arteritis. ( Ehsan, M; Lange, RK; Waxman, J, 1981)
" Nevertheless, persistent use of steroids in high dosage resulted in normalization of both CSF and brain scan abnormalities."1.26Temporal arteritis: cerebrospinal fluid and brain scan abnormalities (case report). ( Gordon, EP; Gordon, M, 1980)
"Mental symptoms are common in temporal arteritis."1.26Reversible mental symptoms in temporal arteritis. ( Cochran, JW; Fox, JH; Kelly, MP, 1978)
"Polymyalgia rheumatica is probably a stage of the same disease."1.26Giant cell arteritis and blindness. ( Sochocky, S, 1977)
"This study describes 44 cases of cranial arteritis (41 of whome had been established by arterial biopsy)."1.25[Neurologic aspects of cranial arteritis]. ( Gloor, B; Hoigné, R; Mumenthaler, M; Wyss, T, 1975)

Research

Studies (525)

TimeframeStudies, this research(%)All Research%
pre-1990166 (31.62)18.7374
1990's112 (21.33)18.2507
2000's122 (23.24)29.6817
2010's99 (18.86)24.3611
2020's26 (4.95)2.80

Authors

AuthorsStudies
Álvarez-Lario, B1
Lorenzo-Martín, JA1
Colazo-Burlato, M1
Macarrón-Vicente, JL1
Alonso-Valdivielso, JL1
Stone, JH14
Spotswood, H1
Unizony, SH8
Aringer, M3
Blockmans, D4
Brouwer, E5
Cid, MC14
Dasgupta, B7
Rech, J3
Salvarani, C15
Spiera, R4
Bao, M3
Rosenberg, H1
Halman, S1
Yadav, K1
Tedeschi, SK1
Jin, Y1
Vine, S1
Lee, H1
Pethoe-Schramm, A1
Yau, V1
Kim, SC1
Dagna, L2
Hellmich, B1
Molloy, E1
Trapnell, BC1
Warrington, KJ8
Wicks, I1
Samant, M1
Zhou, T1
Pupim, L1
Paolini, JF1
Kokloni, IN1
Aligianni, SI1
Makri, O1
Daoussis, D1
Devauchelle-Pensec, V1
Carvajal-Alegria, G1
Dernis, E1
Richez, C1
Truchetet, ME1
Wendling, D2
Toussirot, E1
Perdriger, A1
Gottenberg, JE1
Felten, R1
Fautrel, BJ1
Chiche, L1
Hilliquin, P1
Le Henaff, C1
Dervieux, B1
Direz, G1
Chary-Valckenaere, I1
Cornec, D1
Guellec, D1
Marhadour, T1
Nowak, E1
Saraux, A1
Perricone, C1
Cafaro, G1
Fiumicelli, E1
Bursi, R1
Bogdanos, D1
Riccucci, I1
Gerli, R1
Bartoloni, E1
Montero-Pastor, N1
Sánchez-Costa, JT1
Guerra-Rodríguez, M1
Sánchez-Alonso, F1
Moriano, C1
Loricera, J1
Díaz-González, F1
Boiardi, L6
Galli, E1
Macchioni, P5
Muratore, F4
Klinowski, G1
Hunder, GG20
Casali, M2
Besutti, G1
Spaggiari, L2
Versari, A1
Croci, S2
Mancuso, P1
Rossi, PG1
Marvisi, C1
Matza, MA2
Dagincourt, N1
Mohan, SV1
Pavlov, A3
Han, J3
Trives-Folguera, L1
Molina-Collada, J1
López, K1
Rivera, J1
Serrano-Benavente, B1
Anzola-Alfaro, AM1
Castrejón, I1
Álvaro-Gracia, JM1
Martínez-Barrio, J1
Villiger, PM1
Miler, E1
Stapleton, PP2
Mapplebeck, S2
Mackerness, C2
Gayford, D2
Aung, T1
Wilson, L1
Schofield, P2
Chenevey, RE1
Afkhamnejad, ER1
Martin, TJ1
Sadun, A1
Gordon, L1
Milchert, M1
Brzosko, M1
Serling-Boyd, N1
Fernandes, AD1
Restuccia, G2
Cavazza, A3
Catanoso, M2
Cimino, L2
Aldigeri, R2
Pipitone, N2
Fontana, A1
Ghetu, MV1
Fong, JW1
Chacko, JG2
Chung, SH2
Morcos, MB2
Pollock, PS1
Ng, B2
Luder, Y2
Jogimahanti, AV1
Kini, AT1
Irwin, LE1
Lee, AG4
de Boysson, H3
Liozon, E15
Lambert, M2
Dumont, A2
Boutemy, J2
Maigné, G1
Martin Silva, N1
Ly, KH4
Manrique, A1
Bienvenu, B4
Aouba, A2
Gospe, SM1
Walter, SD1
Bhatti, MT1
Tuckwell, K3
Dimonaco, S3
Klearman, M3
Schett, G2
Schulze-Koops, H2
Collinson, N3
Raine, C1
Merinopoulos, D1
Maw, WW1
Achilleos, K1
Herbaut, A1
Qu-Knafo, L1
Abad, S1
Dhote, R1
Giocanti-Aurégan, A1
Clifford, AH1
Murphy, EM1
Burrell, SC1
Bligh, MP1
MacDougall, RF1
Heathcote, JG1
Castonguay, MC1
Lee, MS1
Matheson, K1
Hanly, JG1
Gutteridge, DH1
Mastaglia, FL1
Jones, O1
Birrell, F1
Uribe, JA1
Aggarwal, I1
Witthayaweerasak, J1
Liao, YJ1
Berry, GJ1
Sab, UK1
Weyand, CM5
Kelly, NP1
Vaidya, A1
Gerhard-Herman, M1
Desai, AS1
Broner, J1
Arnaud, E1
Terré, A1
Lidove, O1
Georges, O1
Mesnildrey, P1
Chennebault, H1
Ziza, JM2
Pioro, MH1
Samson, M4
Devilliers, H2
Maurier, F3
Terrier, B1
Charles, P1
Guillevin, L1
Besancenot, JF2
Fauchais, AL3
Loffroy, R1
Binquet, C1
Audia, S2
Seror, R2
Mariette, X2
Bonnotte, B4
Maghera, S1
Albreiki, D2
Martínez García, P1
Maderuelo Riesco, I1
Tarrazo Tarrazo, C1
Koster, MJ1
Yeruva, K1
Crowson, CS1
Labarca, C1
Cockey, G1
Shah, SR1
Hampton, T1
Strand, V1
Delmas, C1
Dumonteil, S1
Gondran, G1
Bezanahary, H1
VAN DER Geest, KSM1
Sandovici, M1
Chiriac, A1
Badea, C1
Băicuș, C1
Berger, CT1
Daikeler, T3
Ramirez, GA1
Rovere-Querini, P2
Blasi, M1
Sartorelli, S1
Di Chio, MC1
Baldini, M1
De Lorenzo, R1
Bozzolo, EP1
Leone, R1
Mantovani, A1
Manfredi, AA2
Tombetti, E1
Greigert, H1
Ghesquière, T1
Enfrein, A1
Espitia, O1
Bonnard, G1
Agard, C4
Kherani, I1
Chin, C1
Kherani, RB1
Kherani, F1
Creveuil, C1
Ollivier, Y1
Letellier, P1
Pagnoux, C1
Sailler, L5
Pugnet, G3
Souza, AW1
Okamoto, KY1
Abrantes, F1
Schau, B1
Bacchiega, AB1
Shinjo, SK1
Hakman, P1
Vallelian, F2
Nowak, A1
Akın, S1
Tufan, F1
Bahat, G1
Saka, B1
Erten, N1
Karan, MA1
Freeman, AC1
Rapoport, RJ1
Baron, G1
Hachulla, E2
Debandt, M1
Larroche, C1
Puéchal, X1
de Wazieres, B2
Quéméneur, T1
Ravaud, P1
Al Zubidi, N1
Zhang, J1
Spitze, A1
Yalamanchili, S1
Alba, MA4
Mena-Madrazo, JA2
Flores-Suárez, LF2
García-Martínez, A7
Prieto-González, S3
Espígol-Frigolé, G5
Butjosa, M2
Tavera-Bahillo, I2
Rodríguez-Pintó, I1
Hernández-Rodríguez, J7
Hafner, F1
Haas, E1
Belaj, K1
Froehlich, H1
Gary, T1
Eller, P1
Brodmann, M1
Mbagwu, MC1
Weisman, PS1
Kho, AN1
van der Matten, B1
Zandbergen, AA1
Dees, A1
Ferrari, L1
Preziosa, P1
Barcella, V1
Comi, G1
Moiola, L1
Al-Zubidi, N1
Mai, C1
Haykal, HA1
Lobato-Berezo, A1
Alcalde-Villar, M1
Imbernón-Moya, A1
Martínez-Pérez, M1
Aguilar-Martínez, A1
Collado-Ramos, P1
Sane, M1
Selvadurai, A1
Reidy, J1
Higgs, D1
Gonzalez-Fernandez, F1
Lincoff, N1
Ritter, A1
Burow, A1
Schaer, D1
Corbera-Bellalta, M2
Planas-Rigol, E2
Hamilton, KT1
Lee, BJ1
Bourrel, R1
Montastruc, JL1
Lapeyre-Mestre, M1
Rodriguez, EA1
Abraham, T1
Williams, FK1
Ciccia, F1
Rizzo, A1
Guggino, G1
Alessandro, R1
Maugeri, R1
Cannizzaro, A1
Iacopino, DG1
Triolo, G1
Kermani, TA3
Cuthbertson, D1
Carette, S1
Hoffman, GS2
Khalidi, NA1
Koening, CL1
Langford, CA1
Maksimowicz-McKinnon, K1
McAlear, CA1
Monach, PA1
Seo, P1
Merkel, PA2
Ytterberg, SR2
Wallis, KA1
Mumoli, N1
Cei, M1
Vitale, J1
Dentali, F2
Krause, ML1
Norgan, A1
Vella, A1
Beckman, TJ1
Katz-Agranov, N1
Tanay, A1
Bachar, DJ1
Zandman-Goddard, G1
Chen, JJ1
Kardon, RH3
Daley, TJ1
Longmuir, RA1
Newman, KA1
Ahlman, MA1
Hughes, M1
Malayeri, AA1
Pratt, D1
Grayson, PC1
Mednick, Z1
Farmer, J2
Khan, Z1
Warder, D1
Ten Hove, M1
D'Souza, NM1
Morgan, ML1
Almarzouqi, SJ1
Cottrell, DB1
Welch, EC1
Wirsum, C1
Glaser, C1
Gutenberger, S1
Keller, B1
Unger, S1
Voll, RE1
Vach, W1
Ness, T1
Warnatz, K1
Crescentini, F1
Tournier, B1
Janikashvili, N1
Trad, M1
Ciudad, M1
Gautheron, A1
Quipourt, V1
Meaux-Ruault, N1
Magy-Bertrand, N1
Manckoundia, P1
Ornetti, P1
Maillefert, JF2
Ferrand, C1
Mesturoux, L1
Labrousse, F1
Saas, P1
Martin, L1
Buttgereit, F1
Dejaco, C1
Matteson, EL3
Al Belushi, F1
Patel, V1
Gonzalez-Gay, MA12
Castañeda, S2
Llorca, J4
Faurschou, M1
Ahlström, MG1
Lindhardsen, J1
Obel, N1
Baslund, B1
Maleszewski, JJ1
Younge, BR4
Fritzlen, JT1
Goronzy, JJ3
Lorthioir, A1
Marie, I1
Tetart, F1
Bernet, J1
Lévesque, H1
Pou, MA1
Diaz-Torne, C1
Vidal, S1
Corchero, C1
Narvaez, J1
Nolla, JM1
Diaz-Lopez, C1
Donadini, M1
Squizzato, A1
Ageno, W1
Brass, SD1
Durand, ML1
Chen, JW1
Stone, JR2
Winter, M1
Wierzbicka-Hainaut, E1
Anyfantakis, V1
Bonnefoy, M1
Miremont, H1
Bonneric-Malthieu, F1
Guillet, G1
Di Comite, G1
Previtali, P1
Rossi, CM1
Dell'Antonio, G1
Praderio, L1
Corti, A1
Doglioni, C1
Maseri, A1
Sabbadini, MG1
Kok, J1
Lin, M1
Patapanian, H1
Shingde, M1
Lin, P1
Chu, J1
Kosa, SC1
Kumar, N1
Saghir, MK1
Czarnecki, K1
Duggirala, MK1
Dinesh, KP1
Owolabi, A1
Dwyer-Joyce, L1
Cronin, PM1
Schimmer, BM1
Mo, GP1
González, LA1
Santos, OM1
Montoya, J1
Vásquez, G1
Restrepo, JP1
Hurtado, CI1
Correa, LA1
Ramírez, LA1
Cantoni, N1
Meyer, P1
Katan, M1
Kappos, L2
Hess, C1
Deacon, BS1
de Coppet, H1
Charlanne, H1
Launay, D1
Morell-Dubois, S1
Maillard-Lefebvre, H1
Lamotte, C1
Cousin, M1
Hatron, PY2
Husein-Elahmed, H1
Callejas-Rubio, JL2
Rios-Fernández, R1
Ortego-Centeno, N1
Komaroff, AL1
Edvardsson, B1
Eriksson, B1
Palomino-Morales, RJ1
Vazquez-Rodriguez, TR1
Torres, O1
Morado, IC3
Miranda-Filloy, JA1
Fernandez-Gutierrez, B4
Martin, J2
Tsai, TY1
Massasso, D1
Sharma, P1
Crozier, J1
Eizenga, WH1
Hakvoort, L1
Dubbeld, P1
Geijer, RM1
Goudswaard, AN1
Rieck, KL1
Thomsen, KM1
Harmsen, WS1
Karban, MJ1
Zadik, Y1
Findler, M1
Maly, A1
Rushinek, H1
Czerninski, R1
Hotz, C1
Valeyrie-Allanore, L1
Benjoar, MD1
Ortonne, N1
Vitte, E1
Bouvresse, S1
Brun-Buisson, C1
Wolkenstein, P1
Chosidow, O1
Gunderson, CG1
Federman, DG1
Blair, RJ1
Ross, JJ1
Morris, A1
Grudberg, S1
McWilliams, ET1
Dickinson, KK1
Walker, DM1
Raman, V1
Pathak, A1
Dumonteil, N1
Reyes, E1
Quartuccio, L1
Maset, M1
De Maglio, G1
Pontarini, E1
Fabris, M1
Mansutti, E1
Mariuzzi, L1
Pizzolitto, S1
Beltrami, CA1
De Vita, S1
Unizony, S1
Arias-Urdaneta, L1
Miloslavsky, E1
Arvikar, S1
Khosroshahi, A1
Keroack, B1
Tölle, PA1
Kesten, F1
Vallet, AE1
Didelot, A1
Guebre-Egziabher, F1
Bernard, M1
Mauguière, F1
Thurtell, MJ1
Hirota, J1
Kondo, S1
Yamabe, T1
Kondo, T1
Seto, Y1
Suzuki, S1
Lozano, E2
Segarra, M2
Grau, JM5
Rahman, MU2
Kyung, SE1
Yoon, MK1
Crawford, JB1
Horton, JC1
Morotti, A1
Liberini, P1
Padovani, A1
Cornblath, WT2
Calvert, PC1
Fruchter, O1
Ben-Ami, H1
Schapira, D1
Gallimidi, Z1
Gaitini, D1
Goldsher, D1
Hayreh, SS3
Zimmerman, B2
Devogelaer, JP1
Gennari, C1
Chowdhry, IA1
Sinha, J1
Barland, P1
Arruga, J1
Martínez, J1
Roelcke, U1
Eschle, D1
Moschopulos, M1
Laeng, RH1
Buettner, UW1
Monteiro, C1
Fernandes, B1
Reis, I1
Tellechea, O1
Freitas, J1
Figueiredo, A1
Chevalet, P2
Masseau-Imbert, A1
Durand-Fix, MH1
Brisseau, JM1
Rodat, O2
Barrier, JH5
Porcel-Pérez, JM1
Ruiz-González, A1
Foroozan, R1
Deramo, VA1
Buono, LM1
Jayamanne, DG1
Sergott, RC1
Danesh-Meyer, H2
Savino, PJ2
Jover, JA3
Hernández-Garcia, C3
Vargas, E2
Bañares, A3
Spiera, RF1
Kupersmith, M1
Paget, S1
Spiera, H4
Sinnreich, M1
Rossillion, B1
Landis, T1
Burkhard, PR1
Sztajzel, R1
Loustaud-Ratti, V3
Ly, K3
Soria, P4
Vidal, E10
Boutros-Toni, F3
Robert, PY2
Kim, N1
Trobe, JD1
Flint, A1
Keoleian, G1
BIRKHEAD, NC1
WAGENER, HP1
SHICK, RM1
SKARSET, IE1
BERNARD, E1
MICKS, RH1
MUNE, O1
ROSSEL, I1
BETHLENFALVAY, NC1
NUSYNOWITZ, ML1
WHITFIELD, AG1
STOREY, G1
MUNTENDAM, H1
KOTWICA, S1
RUCINSKA, Z1
Thierfelder, C1
Hauser, T1
Proven, A1
Gabriel, SE3
Orces, C1
O'Fallon, WM2
Granel, B1
Serratrice, J1
Ené, N1
Régis, J1
Mouly-Bandini, A1
Drancourt, M1
Disdier, P1
Weiller, PJ1
Nordborg, E2
Nordborg, C1
Nuenninghoff, DM1
Nicoletti, G1
Ciancio, G1
Tardi, S1
Olivieri, I2
Vilardell, C1
Sánchez, M1
Esteban, MJ2
Queralt, C1
Urbano-Márquez, A2
Palacín, A2
Colomer, D1
Bleeker-Rovers, CP1
Bredie, SJ1
van der Meer, JW1
Corstens, FH1
Oyen, WJ1
Catoggio, LJ1
Montero Odasso, M1
Soriano, ER1
Imamura, PM1
Camera, LA1
Mayorga, LM1
Piura, B1
Wolak, A1
Rabinovich, A1
Yanai-Inbar, I1
Pitteloud, N1
Villegas, J1
Dwyer, AA1
Crowley, WF1
McPhaul, MJ1
Hayes, FJ1
Cook, BE1
Bartley, GB1
Hodge, DO1
Nesher, G2
Berkun, Y1
Mates, M1
Baras, M1
Rubinow, A2
Sonnenblick, M2
Younger, DS1
Chiu, CS1
Dryja, TP1
Lessell, S2
Amor-Dorado, JC1
Costa-Ribas, C1
Garcia-Porrua, C6
Fletcher, TM1
Espinola, D1
Graffin, B1
Sauvet, F1
Crémades, S1
Leyral, G1
Jego, C1
Chemsi, M1
Paris, JF1
Carli, P1
Piñeiro, A1
Gomez-Gigirey, A1
Pego-Reigosa, R1
Dierssen-Sotos, T1
Fa'Amatuainu, NA1
Ng, J1
Kumar, S1
Green, G1
Razavi, M1
Jones, RD1
Manzel, K1
Fattal, D1
Rizzo, M1
Santamarina, R1
Armesto, V1
Incalzi, RA1
Gambassi, G1
Bernabei, R1
Gamble, GG1
Blaise, S1
Nadalon, S1
Bayerl, P1
Bandini, F1
Benedetti, L1
Ceppa, P1
Corallo, G1
Ghose, RR1
Ripoll, JM1
Zaragoza, JM1
Bañuls, SR1
Sanchis, AM1
Defuentes, G1
Lecoules, S1
Vedrine, L1
Coutant, G1
Baranger, B1
Algayres, JP1
Solans-Laqué, R1
Pérez-López, J1
Bosch-Gil, JA1
Cohen, S1
Gardner, F1
ter Borg, EJ1
Haanen, HC1
Seldenrijk, CA1
Rimar, D1
Rozenbaum, M1
Zisman, D1
Boulman, N1
Slobodin, G1
Eder, L1
Feld, J1
Rosner, I1
Obuchowska, I1
Mariak, Z1
Budrowski, R1
Mazlumzadeh, M1
Easley, KA1
Calamia, KT1
Griffing, WL1
Kwong, S1
Daniel, A1
Kalra, S1
Houston, S1
Aaron, S1
Chaba, TP1
Majumdar, SR1
Rosselló Aubach, LL1
Torres Cortada, G1
Cabau Rúbies, J1
Aragón Sanz, MA1
Oncins Torres, R1
Sherber, NS1
Olivere, JW1
Martins, CR1
Cheung, PP1
Richards, G1
Unwin, B1
Williams, CM1
Gilliland, W1
Giannini, C1
Miller, DV1
Hunder, G1
Vetter, C1
Bonél, H1
Burkhard, V1
Bielecki, JW1
Müller, BU1
Krüger, K2
Mahevas, M1
Delastour, V1
Bussone, G1
Khellaf, M1
Liou, J1
Grudem, J1
Harris, BT1
Bertoli, AM1
Font, YM1
Nadal, A1
Vilá, LM1
Rendt-Zagar, KE1
Xu, W1
Visvanathan, S1
Fardet, L1
Flahault, A1
Kettaneh, A1
Tiev, KP1
Généreau, T2
Tolédano, C1
Lebbé, C1
Cabane, J2
Randhawa, S1
Van Stavern, GP1
Font, C2
Sanmartí, R1
Cañete, JD1
Garrouste, C1
Astudillo, L1
Lavayssière, L1
Cointault, O1
Borel, C1
Bernard, J1
Arlet, P3
Jang, JJ1
Gorevic, PD1
Olin, JW1
Gonzalez-Juanatey, C1
Lopez-Diaz, MJ1
Farag, N1
Ship, A1
Nigg, C1
Kolyvanos Naumann, U1
Käser, L1
Vetter, W1
Ory, L1
D'Hauthuille, C1
Boutoille, D1
Vincent-Laurent, C1
Mercier, J1
Gooi, P1
Brownstein, S3
Rawlings, N1
Andrade, J1
Al Ali, A1
Saw, J1
Wong, GC1
Ahdab, R1
Thabuy, F1
Menager de Froberville, E1
Brugieres, P1
Hosseini, H1
Sainuddin, S1
Saeed, NR1
Wilske, KR3
Healey, LA4
Ward, LE1
Burbank, MK1
McGowan, BL1
Turiaf, J1
Valère, PE1
Gubler, MC1
Lee, DK1
Andrews, JM1
Kaeser, HE1
Mulder, H3
De Jong, GJ1
Winckers, PL1
Schop, C1
Van der Waa, G1
Gasparini, M1
Dux, S1
Pitlik, S1
Rosenfeld, JB1
Rogez, R1
Lefèvre, JP2
Gil, R2
Neau, JP1
Bataille, B1
Federici, AB1
Fox, RI1
Espinoza, LR1
Zimmerman, TS1
Vinckier, L1
Coget, J1
Devulder, B1
Larson, TS1
Hall, S1
Hepper, NG1
Woodliff, D1
Grau, RG1
Kassan, SS1
Franks, JJ1
Kaplan, H1
Walker, SH1
Tan, EM1
Gerber, NJ1
Mizan, K1
Horoszek-Maziarz, S1
Krupa-Wojciechowska, B1
Koorey, DJ1
Vonesch, HJ1
Dubach, UC1
Chou, CT1
Schumacher, HR1
Schaling, W1
Doury, P2
Fabresse, FX1
Pattin, S2
Eulry, F2
Celton, H1
Larroque, P1
Brandt, KD1
Cohen, AS1
Sack, B1
Hamburger, HA1
Beckman, H1
Thompson, R1
Girotti, F1
Lodrini, S1
Grassi, MP1
Allegranza, A1
Small, P1
Goodman, BW1
Shepard, FA1
Nicolle, DA1
Codère, F1
ten Doesschate, MJ1
Manschot, WA1
Florell, PC1
Sandhaus, L1
Stillman, MT1
Maurel, C1
Masson, C1
Tabaraud, F1
Somerville, W1
Katelaris, CH1
Walls, RS1
Leung, F1
Fam, AG1
Osoba, D1
de Jager, AE1
Walstra, GJ1
Kaufmann, M1
Kahaner, K1
Peselow, ED1
Gershon, S1
Davison, S1
Tang, RA1
Kaldis, LC1
Nightingale, S1
Venables, GS1
Bates, D1
Zauber, NP1
Echikson, AB1
Dimant, J1
Grob, D1
Brunner, NG1
Ehsan, M1
Lange, RK1
Waxman, J1
Bretza, J1
Prete, P1
Martin, D1
Gordon, M1
Gordon, EP1
Soorae, AS1
McKeown, F1
Cleland, J1
Odom, L1
Goldman, JA1
Blumberg, S1
Giansiracusa, DF1
Docken, WP1
Kantrowitz, FG1
Graisely, B1
Audebert, AA1
Offret, H1
de Saint-Maur, PP1
Jones, JG1
Hazleman, BL1
Dautzenberg, PL1
Leijtens, JP1
Ronchetto, F2
Carson, CW1
Beall, LD1
Johnson, CM1
Newman, W1
Lie, JT2
Wolin, MJ1
Kent, AD1
Wiggins, RE1
Rauser, M1
Rismondo, V1
Liu, GT1
Glaser, JS1
Schatz, NJ2
Smith, JL1
Soriano, C1
Morado, C1
Ramos, P1
Herrero, M1
Airoldi, M1
Fantasia, R1
Cotti, D1
Castiglioni, G1
Pelucco, L1
Le Guennec, P1
Dromer, C1
Sixou, L1
Marc, V1
Coustals, P1
Fournié, B1
Orgül, S1
Gass, A1
Flammer, J1
Deraedt, S1
Imbert, JC1
de Heide, LJ2
Pieterman, H1
Hennemann, G1
Weiss, LM1
Gonzalez, E1
Miller, SB1
Agudelo, CA1
Evans, JM2
Batts, KP1
Rosenstein, ED1
Kramer, N1
Gertz, MA1
Bjornsson, J1
Li, CY1
Gans, M1
Larrose, C1
Magadur/Joly, G1
Hamidou, M2
Carrie, F1
Roblot, P4
Bouquet, S1
Delon, A1
Roblot, F1
Becq-Giraudon, B2
Liozon, F6
Gaches, F1
Berdah, JF1
To, KW1
Enzer, YR1
Tsiaras, WG1
Struys, A1
Emilie, D2
Crevon, MC2
Lavignac, C2
Portier, A1
Galanaud, P2
Collazos, J1
García-Moncó, C1
Martín, A1
Rodriguez, J1
Gómez, MA1
Achkar, AA1
Thurnheer, R1
Salomon, F1
Vukov, LF1
Roche, NE1
Fulbright, JW1
Wagner, AD1
Arend, SM1
Westedt, MI1
Bordessoule, D2
Catanzano, G1
Rossi, F2
Casadei-Maldini, M1
Mancini, R2
Beltrandi, E2
Portioli, I2
Rodríguez Gómez, M1
López Barros, G1
Fernández Domínguez, L1
Margusino Framiñán, C1
Jiménez, JL1
Armona, J1
Rodríguez-Valverde, V3
Figueroa, M2
Fernández-Sueiro, JL1
Blanco, R4
Martínez-Taboada, V1
Lau, Y1
Mak, YF1
Hui, PK1
Ahchong, AK1
AbuRrahma, AF1
Thaxton, L1
Grignetti, M1
Carraro, M1
Faccini, L1
van der Veen, MJ1
Dinant, HJ1
van Booma-Frankfort, C1
van Albada-Kuipers, GA1
Bijlsma, JW1
Santiago, J1
Monte, R1
Kachroo, A1
Tello, C1
Bais, R1
Panush, RS1
Moltyaner, Y1
Tenenbaum, J1
Hofmann, RJ1
Morel, F2
Lelievre, E2
Gascan, H1
Wijdenes, J1
Lecron, JC2
Kannan, R1
Allen, CM1
Ockner, SA1
Schneider, KE1
Biais-Sauvètre, MH1
de Groote, D1
Preud'homme, JL1
Meli, B1
Landau, K1
Gloor, BP1
Tomasina, C1
Manzino, M1
Hedderwick, SA1
Bonilla, HF1
Bradley, SF1
Kauffman, CA1
Caramaschi, P1
Biasi, D1
Carletto, A1
Zeminian, S1
Manzo, T1
Bambara, LM1
Melberg, NS1
Grand, MG1
Dieckert, JP1
Barney, NP1
Blumenkranz, MS1
Boone, DE1
Folk, JC1
Stransky, TJ1
Coll-Vinent, B1
López-Soto, A2
Barchuk, WT1
Centeno, L1
Frohman, L1
Bielory, L1
Caselli, RJ2
Bahlas, S1
Ramos-Remus, C1
Davis, P1
Finelli, PF1
Schaufelberger, C1
Bosaeus, I1
Gros, F1
Behin, A1
Guignier, F1
Piroth, C1
Creuzot-Garcher, C1
Tavernier, C1
Eggenberger, E1
Diego, M1
Margo, CE1
González-Rosón, O1
Whittaker, PE1
Fitzsimons, MG1
Martínez-Taboada, VM2
Delgado-Rodriguez, M2
Uriarte, E1
Garcia-Alfranca, F1
Solans, R1
Simeón, C1
Gómez-Lozano, A1
Pérez-Bocanegra, C1
Bosch, JA1
Guevara, RA1
Newman, NJ1
Grossniklaus, HE1
Schippers, EF1
de Meijer, PH1
Meinders, AE1
Marcos, O1
Cebrecos, AI1
Prieto, A1
Sancho de Salas, M1
Rauzy, O1
Fort, M1
Nourhashemi, F1
Alric, L1
Juchet, H3
Ecoiffier, M1
Abbal, M1
Adoue, D1
Dudenhoefer, EJ1
Schatz, MP1
Lacomis, D1
Giuliani, MJ1
Wasko, MC1
Oddis, CV1
Hwang, JM1
Girkin, CA1
Perry, JD1
Lai, JC1
Miller, NR1
Hellmann, DB2
Pía Iglesias, G1
Garrido Sanjuán, JA1
Fandiño Orgeira, JL1
Grandes Ibáñez, J1
González Moraleja, J1
Lee, CC1
Su, WW1
Vázquez-Caruncho, M1
Dababneh, A1
Hajeer, A1
Ollier, WE1
Link, K1
Orenstein, R1
Looney, BD1
Solau-Gervais, E1
Flipo, RM1
Talsma, MA1
Chatterjee, T1
Behrend, P1
Mahler, F1
Baumgartner, I1
Wilke, WS2
Paire, D1
Loustaud, V4
Jauberteau, MO2
Krebs, S1
Gibbons, RB1
Madan, R1
Drehmer, TJ1
Donnelly, TJ1
Saadoun, D1
Cacoub, P2
Costedoat-Chalumeau, N1
Sbai, A1
Piette, JC2
Gissot, V1
Allen, DT1
Voytovich, MC1
Allen, JC1
Fito, C1
Pacheco, MJ1
Altiparmak, MR1
Tabak, F1
Pamuk, ON1
Pamuk, GE1
Mert, A1
Aktuğlu, Y1
Glémarec, J1
el Kouri, D1
Duhamel, E1
Jégo, P1
Maugars, Y1
Planchon, B1
Herrmann, F1
Chemlal, K1
Khalifa, P1
Wechsler, B1
De Gennes, C1
Belmatoug, N1
Cohen, P1
Verdoncq, B1
Carreiro, M1
Ollier, S2
Delobel, P1
Ferrand, D1
Klinger, M1
Casademont, J1
Filella, X1
Fernández-Solà, J1
Airò, P1
Antonioli, CM1
Vianelli, M1
Toniati, P1
Piguet, V1
Friedli, A1
Pessina, PA1
Chavaz, P1
Saurat, JH1
Dalbeth, N1
Lynch, N1
McLean, L1
McQueen, F1
Zwi, J1
Manthorpe, R1
Hansen, TM1
Junker, P1
Lorenzen, I1
Utne, HE1
Lovschall, S1
Gross, MD1
Borkin, MH1
Rupp, S1
Hugod, C3
Scheibel, M2
Enzmann, D1
Scott, WR1
Deding, A1
Tougaard, L1
Krogh Jensen, M1
Rodbro, P1
Cochran, JW1
Fox, JH1
Kelly, MP1
Rosenman, HD1
Lynfield, Y1
Rynes, RI1
Mika, P1
Bartholomew, LE1
Morris, HH1
Sochocky, S1
Fulton, AB1
Lee, RV1
Jampol, LM1
Keltner, JL1
Albert, DM1
Vine, AK1
Sheps, SG2
Allen, GL1
Joyce, JW1
Abruzzo, JL1
Florenzano, F1
Gloger, S1
Donoso, S1
Vergara, F1
Parkes, JD1
Wyss, T1
Mumenthaler, M2
Hoigné, R1
Gloor, B1
Verdich, M1
Nielsen, NV1
Heyn, J1
Halberg, P1
Ghose, MK1
Shensa, S1
Lerner, PI1
Jauberteau-Marchan, MO1
Carmenini, G1
Martusciello, S1
Di Maio, F1
Scioli, A1
Nicoletti, M1
Meloni, F2
Bomholt, C1
Dietrichson, O1
Prause, JU1
Mickley, V1
Kogel, H1
Vogel, U1
Canton, CG1
Bernis, C1
Paraiso, V1
Barril, G1
García, A1
Osorio, C1
Rincón, B1
Traver, JA1
Casadei Maldini, M1
Spacca, C1
Lodi, L1
Montané de la Roque, P1
Le Tallec, Y1
Wind, BE1
Roig López de los Mozos, A1
Calvo Catalá, J1
Hortelano Martínez, E1
Liñana Santafé, JJ1
González-Cruz Cervellera, MI1
Ballester Belda, JE1
Aburahma, AF1
Witsberger, TA1
Ruiz Morales, MJ1
Gómez Huelgas, R1
Sanz Moreno, J1
de la Torre Solís, C1
Danziger, N1
De Broucker, T1
Margent, P1
Millot, E1
Soria, C1
González-Herrada, CM1
García-Almagro, D1
Díaz, R1
Piris, MA1
Orradre, JL1
Jonkhoff, AR1
Gans, RO1
Lantin, JP1
Duc, J1
Crayton, HE1
Sundstrom, WR1
Donada, C1
Maccioni, A1
Zambon, G1
Austin, DG1
Attanasio, R1
Susmano, A1
Roseman, D1
Haber, MH1
Venot, J1
Weinbreck, P1
Voigt, H1
Vierke, A1
Hoffmann, W1
Bassermann, R1
Barsekow, F1
Ninet, JP1
Bachet, P1
Dumontet, CM1
Du Colombier, PB1
Stewart, MD1
Pasquier, JH1
Grodum, E1
Petersen, HA1
Auquier, L1
Paolaggi, JB1
Hackeng, WH1
vd Lely, AJ1
Siersema-Smallegange, M1
Bridges, AJ1
Porter, J1
England, D1
Faarvang, KL1
Pontoppidan Thyssen, E1
Richard, AJ1
Krall, PL1
Mazanec, DJ1
Thomson, GT1
Johnston, JL1
Sharpe, JA1
Inman, RD1
Suchnicka, R1
Jankowska, R1
Małolepszy, J1
Patsner, B1
Pitzele, S1
Mann, WJ1
Chalas, E1
Campo, E1
Ercilla, G1
Vilaseca, J1
Villalta, J1
Ingelmo, M1
Pascuzzi, RM1
Roos, KL1
Davis, TE1
Grimaldi, A1
Saint-Jean, O1
Bosquet, F1
Pennaforte, S1
Gouet, D1
Maréchaud, R1
Le Berre, D1
Alcalay, M1
Boissonnot, L1
Bontoux, D1
Risse, JF1
Chadenas, D1
Picon, L1
Roux, C1
Gauvain, JB1
Maitre, F1
Buzacoux, J1
Gorphe, T1
Jay, WM1
Nazarian, SM1
Wysenbeek, AJ1
Leibovici, L1
Mor, F1
Atsmon, A1
Friedman, G1
Friedman, B1
Elling, H1
Elling, P1
Kujala, GA1
Halpin, DP1
Moran, KT1
Jewell, ER1
Robb-Nicholson, C1
Chang, RW1
Anderson, S1
Roberts, WN1
Longtine, J1
Corson, J1
Larson, M1
George, D1
Green, J1
Bryant, G1
Fernandez-Herlihy, L2
Thomas, JW1
Vertkin, A1
Nell, LJ1
Fiolet, JF1
van Santen-Hoeufft, HM1
Gudevenos, J1
Nikolaou, N1
Stefanou, D1
Helfrich, DJ1
Mulhern, LM1
Luparello, FJ1
Smith, W1
Ljønes, F1
Tenstad, O1
Wolfovitz, E1
Levy, Y1
Brook, JG1
Lipton, RB2
Rosenbaum, D1
Mehler, MF1
Pereira, M1
Kaine, JL1
Huddleston, RE1
Papadakis, MA1
Schwartz, ND1
Di Giacomo, V1
Nigro, D1
Trocchi, G1
Verallo, P1
Bottazzi, M1
Bellisario, G1
Wilsher, ML1
Glasgow, GL1
Truong, L1
Kopelman, RG1
Williams, GS1
Pirani, CL1
Scharre, D1
Petri, M1
Engman, E1
DeArmond, S1
Klinkhoff, AV1
Reid, GD1
Moscovich, M1
Bella Cueto, F1
Costa Roma, J1
González de Zárate, P1
Pujol Farriol, R1
Aguirre Errasti, L1
Martínez L de Letona, J1
Hory, B1
Blanc, D1
Solomon, S1
Wertenbaker, C1
Wadman, B2
Werner, I2
Harrison, MJ1
Bevan, AT1
Warrell, DA1
Godfrey, S1
Olsen, EG1
Tallgren, LG1
von Knorring, J1
Henkind, P1
Charles, NC1
Pearson, J1
Beevers, DG1
Harpur, JE1
Turk, KA1
Cabanel, G1
Voog, R1
Phelip, X1
Verdier, JM1
Fabris, F1
Doglio, R1
Lindeboom, GA1
Roomet, A1
Allen, JS1
Sölch, G1
Kiesewetter, R1
Vojtìsek, O1
Kankovà, D1
Fauchald, P2
Rygvold, O2
Oystese, B1
Johnston, AC1
Dickson, ER1
Maldonado, JE1
Cain, JA1
Uriu, SA1
Reinecke, RD1
Kanter, SF1
Moskal, J1
Ujwary, S1
Siegenthaler, W1
Kogstad, O1
Thomas, RD1
Croft, DN1
Appenzeller, O1
Wagner, A3
Annweiler, J1
Kraus, E1
Dillmann, G1
Conradi, S1
Werneck, LC1
Coelho, A1
Schlezinger, NS1
Muzaferija, A1
Novosel, D1
Plotz, CM1
Gutrecht, JA1
Sigstad, H1
Ulstrup, JC1
Riediger, P1
Goder, G1
Comberg, U1
Grahame, R1
Bluestone, R1
Holt, PJ1
Braun, U1
Simkin, PA1
Petera, V1
Kogstad, OA1
Smith, WH1
Billings, J1
Davis, AE1
Davis, TP1

Clinical Trials (18)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase III, Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Assess the Efficacy and Safety of Tocilizumab in Subjects With Giant Cell Arteritis[NCT01791153]Phase 3251 participants (Actual)Interventional2013-07-22Completed
A Phase 2, Randomized, Double-blind Placebo-controlled Study to Test the Efficacy and Safety of KPL-301 in Giant Cell Arteritis[NCT03827018]Phase 270 participants (Actual)Interventional2018-09-20Completed
Efficacy and Safety of Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica (ITTG PMR): An Open-label 52-week Randomized Controlled Trial[NCT06172361]Phase 398 participants (Anticipated)Interventional2024-01-15Not yet recruiting
Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE[NCT02908217]Phase 3113 participants (Actual)Interventional2017-02-15Completed
Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis[NCT02955147]Phase 1/Phase 213 participants (Actual)Interventional2016-12-01Terminated (stopped due to Inefficacy)
CORON-ACT - a Multicenter, Double-blind, Randomized Controlled Phase II Trial on the Efficacy and Safety of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)[NCT04335071]Phase 25 participants (Actual)Interventional2020-04-26Terminated (stopped due to "1.) Not possible to recruit the planned number of patients during the planned study period; 2.) Dexamethason was included in the standard of care for the study population during the course of the study and inclusion criteria could no longer be met.")
Is the Melanocortin System Involved in Inflammatory Resolution[NCT05681676]9 participants (Actual)Observational2012-03-01Completed
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission: a Prospective, Pilot Study.[NCT03244709]Phase 415 participants (Anticipated)Interventional2015-01-01Recruiting
Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course[NCT04204876]40 participants (Anticipated)Observational2020-05-28Recruiting
Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.[NCT01910038]Phase 220 participants (Actual)Interventional2013-11-08Completed
HECTHOR: A Pilot Multicenter Double-blind Randomised Study of 3 Months Treatment With Humira Added to Steroids in Giant Cell Arteritis[NCT00305539]Phase 369 participants (Actual)Interventional2006-05-31Completed
Biomarkers in Giant Cells Arteritis[NCT02844023]100 participants (Actual)Interventional2015-01-31Terminated (stopped due to recruitment failure)
Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study[NCT02101333]Phase 318 participants (Actual)Interventional2014-06-10Completed
A Randomized, Controled, Open Label Trial: Comparison Between Two Standardized Corticosteroids Tapering, Respectively Short (North American) and Long (European), in Giant Cell Arteritis[NCT04012905]Phase 3150 participants (Anticipated)Interventional2020-11-05Not yet recruiting
Multicentric Double Blind Versus Placebo Randomised Study Evaluating the Corticosteroid Sparing Effect of Hydrocyschloroquine in Non Complicated Giant Cell Arteritis.[NCT00430807]Phase 375 participants (Actual)Interventional2002-01-31Completed
A Randomized, Double-Masked, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Infliximab in Subjects With Giant Cell Arteritis[NCT00076726]Phase 244 participants (Actual)Interventional2003-11-30Terminated (stopped due to Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative glucocorticosteroid dosage)
Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease[NCT01981889]Phase 453 participants (Actual)Interventional2013-10-31Completed
A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794]Phase 394 participants (Anticipated)Interventional2019-03-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Area Under the Curve From Time Zero to End of Dosing Interval (AUCtau) at Steady State of Tocilizumab

AUCtau is the model-predicted area under the tocilizumab serum concentration versus time curve from time zero to the end of dosing interval. AUCtau is measured in microgram*day per milliliter (mcg*day/mL). (NCT01791153)
Timeframe: Baseline and Week 16 (Predose [Hour 0], 24, 48, 72, 96, and 120 or 144 hours postdose); Weeks 1, 2, 17, and 18 (Predose [Hour 0])

Interventionmcg*day/mL (Mean)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper499.2
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper227.2

Maximum Serum Concentration at Steady State (Cmax,ss) of Tocilizumab

Cmax,ss is maximum model-predicted serum steady state concentration of tocilizumab measured in micrograms per milliliter (mcg/mL). (NCT01791153)
Timeframe: Baseline and Week 16 (Predose [Hour 0], 24, 48, 72, 96, and 120 or 144 hours postdose); Weeks 1, 2, 17, and 18 (Predose [Hour 0])

Interventionmcg/mL (Mean)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper73
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper19.3

Minimum Serum Concentration at Steady State (Cmin,ss) of Tocilizumab

Cmin,ss is minimum model-predicted serum steady state concentration of tocilizumab measured in mcg/mL. (NCT01791153)
Timeframe: Baseline and Week 16 (Predose [Hour 0], 24, 48, 72, 96, and 120 or 144 hours postdose); Weeks 1, 2, 17, and 18 (Predose [Hour 0])

Interventionmcg/mL (Mean)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper68.1
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper11.1

Percentage of Participants in Sustained Remission at Week 52 (Tocilizumab + 26 Weeks Prednisone Taper Versus Placebo + 26 Weeks Prednisone Taper)

Remission was defined as the absence of flare and normalization of the C-reactive protein (CRP) (less than [<] 1 milligram per deciliter [mg/dL]). Sustained remission was defined as the absence of flare following induction of remission within 12 weeks of randomization and maintained up to Week 52. Flare was determined by the investigator and was defined as the recurrence of signs or symptoms of GCA and/or erythrocyte sedimentation rate (ESR) greater than or equal to (>/=) 30 millimeters per hour (mm/hr) attributable to GCA. A single CRP elevation (>/=1 mg/dL) was not considered as a sign of flare, unless the CRP remained elevated (>/=1 mg/dL) at the next study visit. (NCT01791153)
Timeframe: Week 52

Interventionpercentage of participants (Number)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper56.0
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper53.1
Part 1: Placebo + 26 Weeks Prednisone Taper14.0

Percentage of Participants in Sustained Remission at Week 52 (Tocilizumab + 26 Weeks Prednisone Taper Versus Placebo + 52 Weeks Prednisone Taper)

Remission was defined as the absence of flare and normalization of the CRP (<1 mg/dL). Sustained remission was defined as the absence of flare following induction of remission within 12 weeks of randomization and maintained up to Week 52. Flare was determined by the investigator and was defined as the recurrence of signs or symptoms of GCA and/or ESR >/=30 mm/hr attributable to GCA. A single CRP elevation (>/=1 mg/dL) was not considered as a sign of flare, unless the CRP remained elevated (>/=1 mg/dL) at the next study visit. (NCT01791153)
Timeframe: Week 52

Interventionpercentage of participants (Number)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper56.0
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper53.1
Part 1: Placebo + 52 Weeks Prednisone Taper17.6

Percentage of Participants With Anti-Tocilizumab Antibodies

All samples were tested by screening assay, and those samples that were positive were further analyzed by a confirmation assay to confirm specificity. Percentage of participants who has a positive confirmation assay result any time after the initial drug administration with a negative confirmation assay result at baseline was reported. (NCT01791153)
Timeframe: Baseline up to Week 52

Interventionpercentage of participants (Number)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper1.1
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper6.5
Part 1: Placebo + 26 Weeks Prednisone Taper2.0
Part 1: Placebo + 52 Weeks Prednisone Taper2.1

Time to First GCA Disease Flare

Flare was determined by the investigator and was defined as the recurrence of signs or symptoms of GCA and/or ESR >/=30 mm/hr attributable to GCA. Participants who withdrew from the study prior to Week 52 were censored from the time of withdrawal. (NCT01791153)
Timeframe: Up to 52 weeks

Interventiondays (Median)
Part 1: Tocilizumab qw + 26 Weeks Prednisone TaperNA
Part 1: Tocilizumab q2w + 26 Weeks Prednisone TaperNA
Part 1: Placebo + 26 Weeks Prednisone Taper165.0
Part 1: Placebo + 52 Weeks Prednisone Taper295.0

Total Cumulative Prednisone Dose

The median total cumulative prednisone dose over the 52 weeks for each treatment group and the corresponding 95% confidence intervals are presented. (NCT01791153)
Timeframe: Up to 52 weeks

Interventionmilligrams (mg) (Median)
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper1862.00
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper1862.00
Part 1: Placebo + 26 Weeks Prednisone Taper3296.00
Part 1: Placebo + 52 Weeks Prednisone Taper3817.50

C-Reactive Protein (CRP) Level

The test for CRP is a laboratory measurement for evaluation of an acute phase reactant of inflammation through the use of an ultrasensitive assay. A decrease in the level of CRP indicates reduction in inflammation and therefore improvement. (NCT01791153)
Timeframe: Baseline and Week 52

,,,
Interventionmilligrams per liter (mg/L) (Median)
Baseline (n=100,49,50,51)Week 52 (n=76,35,35,33)
Part 1: Placebo + 26 Weeks Prednisone Taper3.644.90
Part 1: Placebo + 52 Weeks Prednisone Taper3.568.12
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper4.520.33
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper3.670.30

Change From Baseline in Patient Global Assessment (PGA) of Disease Activity Assessed Using Visual Analogue Scale (VAS) at Week 52

Participants assessed their current disease activity on a 0-100 millimeter (mm) VAS, where 0 mm = no disease activity and 100 mm = maximum disease activity. A negative change from baseline indicates improvement. (NCT01791153)
Timeframe: Baseline, Week 52

,,,
Interventionmm (Mean)
Baseline (n=100,49,49,51)Change at Week 52 (n=60,26,11,18)
Part 1: Placebo + 26 Weeks Prednisone Taper35.73-8.45
Part 1: Placebo + 52 Weeks Prednisone Taper47.78-10.00
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper46.65-22.69
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper43.61-19.68

Change From Baseline in Short Form (SF)-36 Questionnaire Score at Week 52

The SF-36 is a standardized questionnaire used to assess physical functioning and is made up of eight domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional and Mental Health. Transforming and standardizing these domains leads to the calculation of the Physical Component Score (PCS) and Mental Component Score (MCS). The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning). A positive change from baseline indicates improvement. No imputation was used for missing data. Data was set to missing for participants who received escape therapy. (NCT01791153)
Timeframe: Baseline, Week 52

,,,
Interventionunits on a scale (Mean)
PCS: Baseline (n=97,49,48,49)PCS: Change at Week 52 (n=59,26,9,18)MCS: Baseline (n=97,49,48,49)MCS: Change at Week 52 (n=59,26,9,18)
Part 1: Placebo + 26 Weeks Prednisone Taper42.652.0842.734.99
Part 1: Placebo + 52 Weeks Prednisone Taper41.12-2.8040.452.60
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper40.622.7147.671.98
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper43.105.3742.778.21

Erythrocyte Sedimentation Rate (ESR)

ESR is a laboratory test that provides a non-specific measure of inflammation. The test assesses the rate at which red blood cells fall in a test tube. Normal range is 0-30 mm/hr. A higher rate is consistent with inflammation. (NCT01791153)
Timeframe: Baseline and Week 52

,,,
Interventionmm/hr (Median)
Baseline (n=99,49,50,51)Week 52 (n=76,35,35,33)
Part 1: Placebo + 26 Weeks Prednisone Taper23.0020.00
Part 1: Placebo + 52 Weeks Prednisone Taper20.0024.00
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper15.005.00
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper19.003.00

Minimum Observed Serum Concentration (Ctrough) of Tocilizumab

Ctrough is minimum observed serum concentration of tocilizumab measured in mcg/mL. (NCT01791153)
Timeframe: Predose (Hour 0) at Baseline and Week 52

,
Interventionmcg/mL (Mean)
Baseline (n= 99, 48)Week 52 (n= 72, 33)
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper0.0012.22
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper0.0767.93

Serum Interleukin-6 (IL-6) Level

(NCT01791153)
Timeframe: Baseline and Week 52

,,,
Interventionpicograms per milliliter (pg/mL) (Mean)
Baseline (n=91,44,50,47)Week 52 (n=69,32,28,30)
Part 1: Placebo + 26 Weeks Prednisone Taper12.7335.96
Part 1: Placebo + 52 Weeks Prednisone Taper8.3110.85
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper16.2952.70
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper8.7965.99

Serum Soluble IL-6 Receptor (sIL-6R) Level

(NCT01791153)
Timeframe: Baseline and Week 52

,,,
Interventionnanograms per milliliter (ng/mL) (Mean)
Baseline (n=99,48,50,50)Week 52 (n=73,33,33,31)
Part 1: Placebo + 26 Weeks Prednisone Taper42.0776.44
Part 1: Placebo + 52 Weeks Prednisone Taper40.3764.80
Part 1: Tocilizumab q2w + 26 Weeks Prednisone Taper50.82464.30
Part 1: Tocilizumab qw + 26 Weeks Prednisone Taper51.34600.53

Cumulative Corticosteroid Dose at the End of the Washout Safety Follow-up Period

(NCT03827018)
Timeframe: Final Safety Follow-up visit (Week 38)

Interventionmg (Mean)
Mavrilimumab2464.93
Placebo2845.45

Cumulative Corticosteroid Dose at Week 26

(NCT03827018)
Timeframe: Week 26

Interventionmg (Mean)
Mavrilimumab2074.15
Placebo2402.98

Percentage of Participants Who Completed the 26-Week Corticosteroid Taper and Who Had a Normal CRP Level

Participants were considered to have completed the corticosteroid taper if by week 26 receiving 1 mg/day for those who start with 60 mg/day, or 0 mg/day for those who start with doses < 60 mg/day. 95% CI calculated using Clopper-Pearson confidence intervals. (NCT03827018)
Timeframe: Week 26

Interventionpercentage of participants (Number)
Mavrilimumab23.8
Placebo14.3

Percentage of Participants Who Completed the 26-Week Corticosteroid Taper and Who Had a Normal ESR

Participants were considered to have completed the corticosteroid taper if by week 26 receiving 1 mg/day for those who start with 60 mg/day, or 0 mg/day for those who start with doses < 60 mg/day. 95% CI calculated using Clopper-Pearson confidence intervals. (NCT03827018)
Timeframe: Week 26

Interventionpercentage of participants (Number)
Mavrilimumab45.2
Placebo14.3

Percentage of Participants Who Completed the 26-week Corticosteroid Taper and Who Had No Signs or Symptoms of GCA Nor New or Worsening Vasculitis by Imaging by Week 26

Participants were considered to have completed the corticosteroid taper if by week 26 receiving 1 mg/day for those who start with 60 mg/day, or 0 mg/day for those who start with doses < 60 mg/day. 95% CI calculated using Clopper-Pearson confidence intervals. (NCT03827018)
Timeframe: Week 26

Interventionpercentage of participants (Number)
Mavrilimumab71.4
Placebo32.1

Sustained Remission Rate at Week 26

The sustained remission rate at Week 26 is defined as the percentage of participants with sustained remission, as assessed by independent adjudication, at Week 26, derived from the time to flare curve. Kaplan-Meier Survival Estimates with standard error and 95% CI for each arm. Participants who completed the treatment period without a flare by Week 26 were considered to have sustained remission. (NCT03827018)
Timeframe: Week 26

Interventionpercentage of participants (Number)
Mavrilimumab83.2
Placebo49.9

Time to Elevated C-Reactive Protein (CRP) by Week 26

Elevated CRP is defined as first occurrence of CRP value ≥ 1.0 mg/dL. Participants with elevated CRP within 3 days of first dose are excluded from the analysis. Kaplan-Meier method used to estimate the survival functions for each treatment arm. (NCT03827018)
Timeframe: Week 26

Interventionweeks (Median)
MavrilimumabNA
Placebo12.3

Time to Elevated Erythrocyte Sedimentation Rate (ESR) by Week 26

Elevated ESR is defined as first occurrence of ESR value ≥ 30 mm/hr. Participants with elevated ESR within 3 days of first dose are excluded from the analysis. Kaplan-Meier method used to estimate the survival functions for each treatment arm. (NCT03827018)
Timeframe: Week 26

Interventionweeks (Median)
Mavrilimumab26.1
Placebo12.1

Time to Flare by Week 26

"Time to flare by Week 26 was defined as time from randomization to the date of first flare occurring within the 26-week period, as assessed by independent adjudication. Kaplan-Meier method used to estimate the survival functions for each treatment arm.~Flare/relapse was defined as a C-reactive protein (CRP) of 1 mg/dL or greater and/or erythrocyte sedimentation rate (ESR) of 30 mm/h or greater AND at least one of the following signs or symptoms attributed to GCA: Cranial symptoms (new-onset localized headache; scalp or temporal artery tenderness; ischemic-related vision loss; unexplained mouth or jaw pain upon mastication; transient ischemic attack or stroke related to GCA); Extracranial symptoms (claudication of the extremities; symptoms of polymyalgia rheumatica); New or worsening angiographic abnormalities detected via MRI, CT/CTA, or PET-CT of the aorta or other great vessels or via ultrasound of the temporal arteries." (NCT03827018)
Timeframe: Week 26

Interventionweeks (Median)
MavrilimumabNA
Placebo25.1

Time to Signs/Symptoms of Giant Cell Arteritis (GCA) or New or Worsening Vasculitis on Imaging by Week 26

Kaplan-Meier method used to estimate the survival functions for each treatment arm. (NCT03827018)
Timeframe: Week 26

Interventionweeks (Median)
MavrilimumabNA
Placebo25.1

Cumulative Prednisone Dose

(NCT02955147)
Timeframe: 52 weeks

Interventionmg of prednisone (Mean)
Ustekinumab Plus Prednisone2289

Number of Participants With at Least One Adverse Event

(NCT02955147)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
Ustekinumab Plus Prednisone12

Number of Participants With Disease Flare

Disease relapse was defined as the recurrence of signs or symptoms of GCA (e.g., cranial or PMR) that required treatment intensification, regardless of the ESR and CRP levels. (NCT02955147)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
Ustekinumab Plus Prednisone7

Percentage of Patients in Glucocorticoid-free Remission

The primary study endpoint, prednisone-free remission, was defined as: 1) absence of relapse from the time that remission was achieved through week 52; 2) normalization of ESR (<40 mm/hour) and CRP (<10 mg/L); and, 3) adherence to the protocol prednisone taper. (NCT02955147)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
Ustekinumab Plus Prednisone3

Reviews

53 reviews available for prednisone and Aortic Arteritis, Giant Cell

ArticleYear
Vision loss in giant cell arteritis: case-based review.
    Rheumatology international, 2022, Volume: 42, Issue:10

    Topics: Aged; Blindness; Giant Cell Arteritis; Humans; Male; Optic Neuropathy, Ischemic; Prednisone; Vision

2022
Recent advances in the diagnosis and management of giant cell arteritis.
    Current opinion in rheumatology, 2020, Volume: 32, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Biopsy; Giant Cell Arteritis; Glucocorticoids; Humans; Positron E

2020
Diagnosis and management of polymyalgia rheumatica.
    The Practitioner, 2016, Volume: 260, Issue:1799

    Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumati

2016
Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2018, Volume: 38, Issue:1

    Topics: Aged; Autoantibodies; Autoantigens; Blindness; Computed Tomography Angiography; Female; Giant Cell A

2018
Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Primary care, 2018, Volume: 45, Issue:2

    Topics: Aged; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Middle Aged; Poly

2018
[Treatment of giant cell arteritis].
    Presse medicale (Paris, France : 1983), 2019, Volume: 48, Issue:9

    Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Azat

2019
[Aortitis in giant cell arteritis: Diagnosis, prognosis and treatment].
    Presse medicale (Paris, France : 1983), 2019, Volume: 48, Issue:9

    Topics: Adrenal Cortex Hormones; Aortic Aneurysm; Aortic Dissection; Aortic Rupture; Aortitis; Computed Tomo

2019
Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
    Seminars in arthritis and rheumatism, 2013, Volume: 43, Issue:1

    Topics: Aged; Aged, 80 and over; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combinati

2013
[Treatment of giant cell arteritis].
    La Revue de medecine interne, 2013, Volume: 34, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Biomarkers; Disease Progression; Giant Cell Arteritis; Glucocorti

2013
[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
    Praxis, 2014, Aug-20, Volume: 103, Issue:17

    Topics: Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Femoral Neck Fractures

2014
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    JAMA, 2016, Jun-14, Volume: 315, Issue:22

    Topics: Antibodies, Monoclonal, Humanized; Diagnostic Imaging; Drug Administration Schedule; Giant Cell Arte

2016
[Superficial cranial venous thromboses preceding the diagnosis of giant cell arteritis].
    Journal des maladies vasculaires, 2010, Volume: 35, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Biopsy; Female; Forehead; Giant Cell Arteritis; Head

2010
Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Acta ophthalmologica Scandinavica, 2002, Volume: 80, Issue:4

    Topics: Aged; Aged, 80 and over; Biopsy; Dexamethasone; Female; Giant Cell Arteritis; Glucocorticoids; Human

2002
Brachial plexopathy as a presenting symptom of giant cell arteritis.
    The Journal of rheumatology, 2002, Volume: 29, Issue:12

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Brachial Plexus Neuropathies; Diagnosis, Diffe

2002
Recovery of visual function in patients with biopsy-proven giant cell arteritis.
    Ophthalmology, 2003, Volume: 110, Issue:3

    Topics: Aged; Aged, 80 and over; Biopsy; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Infusions, I

2003
Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
    Ophthalmology, 2003, Volume: 110, Issue:6

    Topics: Aged; Aged, 80 and over; Biopsy; Blood Sedimentation; C-Reactive Protein; Dexamethasone; Female; Gia

2003
Giant cell arteritis: strategies in diagnosis and treatment.
    Current opinion in rheumatology, 2004, Volume: 16, Issue:1

    Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Prednisone; Ultrasonograp

2004
Giant cell arteritis of the female genital tract.
    Clinical and experimental obstetrics & gynecology, 2004, Volume: 31, Issue:1

    Topics: Aged; Female; Genital Diseases, Female; Giant Cell Arteritis; Glucocorticoids; Humans; Ovarian Cysts

2004
[Simple Horton's syndrome: modalities of treatment].
    Presse medicale (Paris, France : 1983), 2004, Jan-24, Volume: 33, Issue:1

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anticoagulants; Giant Cell Arteritis; Humans; Ost

2004
[Complicated Horton's syndrome: therapeutic modalities].
    Presse medicale (Paris, France : 1983), 2004, Jan-24, Volume: 33, Issue:1

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anticoagulants; Drug Resistance; Giant Cell Arter

2004
Vasculitis of the nervous system.
    Current opinion in neurology, 2004, Volume: 17, Issue:3

    Topics: Azathioprine; Connective Tissue Diseases; Cyclophosphamide; Diagnosis, Differential; Giant Cell Arte

2004
[Horton's disease].
    La Revue du praticien, 2005, Jan-31, Volume: 55, Issue:2

    Topics: Biopsy; Fever; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone; Temporal Arteries

2005
[Horton's disease revealed by brachial C5 plexopathy].
    La Revue de medecine interne, 2005, Volume: 26, Issue:7

    Topics: Aged; Anti-Inflammatory Agents; Biopsy; Brachial Plexus Neuropathies; Drug Therapy, Combination; Fem

2005
Polymyalgia rheumatica and giant cell arteritis.
    American family physician, 2006, Nov-01, Volume: 74, Issue:9

    Topics: Aged; Diagnosis, Differential; Diagnostic Imaging; Giant Cell Arteritis; Glucocorticoids; Humans; Mi

2006
Vasculitis: a collection of pearls and myths.
    Rheumatic diseases clinics of North America, 2007, Volume: 33, Issue:4

    Topics: Antirheumatic Agents; Behcet Syndrome; Churg-Strauss Syndrome; Cyclophosphamide; Giant Cell Arteriti

2007
Five clinical conundrums in the management of giant cell arteritis.
    Rheumatic diseases clinics of North America, 2007, Volume: 33, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Aorta; Aortography; Azathioprine; Dilatation, Pathologic; Giant

2007
[Therapy of polymyalgia rheumatica].
    La Clinica terapeutica, 1984, Jul-15, Volume: 110, Issue:1

    Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anti-Inflammatory Agents; Benzodiazepines; Benzothiadiaz

1984
[The risks of delay in steroid therapy for confirming by biopsy a clinical diagnosis of temporal arteritis. A case of sudden blindness].
    Recenti progressi in medicina, 1995, Volume: 86, Issue:3

    Topics: Aged; Aged, 80 and over; Biopsy; Blindness; Giant Cell Arteritis; Humans; Male; Prednisone; Risk Fac

1995
[Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients].
    Revue du rhumatisme (Ed. francaise : 1993), 1994, Volume: 61, Issue:7-8

    Topics: Aged; Aged, 80 and over; Antimalarials; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Pre

1994
[Specific respiratory manifestations of Horton disease].
    La Revue de medecine interne, 1994, Volume: 15, Issue:12

    Topics: Female; Giant Cell Arteritis; Humans; Male; Prednisone; Respiratory Tract Diseases

1994
Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.
    Clinical rheumatology, 1994, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone

1994
[Clinical course of Horton disease. Apropos of 42 cured patients].
    Annales de medecine interne, 1994, Volume: 145, Issue:4

    Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednison

1994
[Giant cell arteritis. A study of 191 patients].
    Medicina clinica, 1995, Dec-02, Volume: 105, Issue:19

    Topics: Aged; Aged, 80 and over; Biopsy; Blindness; Cause of Death; Female; Giant Cell Arteritis; Humans; Ma

1995
[An atypical presentation of a case of Horton's giant-cell arteritis].
    Minerva medica, 1995, Volume: 86, Issue:12

    Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Biopsy; Candidiasis; Drug Hypersensitiv

1995
Temporal arteritis: a review and case history.
    The Journal of family practice, 1996, Volume: 43, Issue:3

    Topics: Aged; Anemia; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Prednisone

1996
Giant cell (temporal) arteritis.
    Neurologic clinics, 1997, Volume: 15, Issue:4

    Topics: Adrenal Cortex Hormones; Cerebrovascular Disorders; Cranial Nerve Diseases; Giant Cell Arteritis; Hu

1997
Polymyalgia rheumatica. Relief can be dramatic.
    Mayo Clinic health letter (English ed.), 1998, Volume: 16, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Giant Cell Arteritis; Glucocorticoids; Humans

1998
Giant cell arteritis with ocular complications discovered simultaneously in two sisters.
    Clinical rheumatology, 1998, Volume: 17, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Eye Diseases; Female; Giant Cell Arteriti

1998
Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis.
    Southern medical journal, 1999, Volume: 92, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Bacteremia; Enterococcus faecalis; Giant Cell Arteritis; Gram-Pos

1999
Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia.
    Military medicine, 1996, Volume: 161, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Drug Therapy, Combination; Fatal Outcome; Fema

1996
[Horton's disease and corticosteroid-responsive hearing loss].
    Annales de medecine interne, 2000, Volume: 151, Issue:7

    Topics: Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Glucocorticoids; Hearing Loss, Bilater

2000
Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Seminars in arthritis and rheumatism, 2001, Volume: 30, Issue:4

    Topics: C-Reactive Protein; CD8-Positive T-Lymphocytes; Flow Cytometry; Giant Cell Arteritis; Hematologic Te

2001
[Bilateral brachial claudication as the initial manifestation of giant cell arteritis. Case report and review of the literature].
    VASA. Zeitschrift fur Gefasskrankheiten, 1992, Volume: 21, Issue:4

    Topics: Aged; Brachial Artery; Combined Modality Therapy; Diabetic Angiopathies; Endarterectomy; Female; Gia

1992
Renal failure in temporal arteritis.
    American journal of nephrology, 1992, Volume: 12, Issue:5

    Topics: Aged; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Kid

1992
Temporal arteritis. Aggressive treatment prevents visual complications.
    Postgraduate medicine, 1992, May-01, Volume: 91, Issue:6

    Topics: Adrenal Cortex Hormones; Clinical Protocols; Giant Cell Arteritis; Humans; Male; Methylprednisolone;

1992
[Temporal arteritis: diagnostic and therapeutic approach. What is new?].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1991, Apr-09, Volume: 80, Issue:15

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Giant Cell Arteritis; Polymyalgia Rheumatica; Predn

1991
Giant cell arteritis and polymyalgia rheumatica.
    Hospital practice (Office ed.), 1990, Nov-15, Volume: 25, Issue:11

    Topics: Aged; Biopsy; Diagnosis, Differential; Drug Administration Schedule; Female; Fibromyalgia; Giant Cel

1990
Giant cell arteritis of the breast. A unique syndrome.
    Archives of internal medicine, 1990, Volume: 150, Issue:4

    Topics: Arteries; Breast; Breast Diseases; Female; Giant Cell Arteritis; Humans; Middle Aged; Prednisone

1990
Giant cell (temporal) arteritis.
    Rheumatic diseases clinics of North America, 1990, Volume: 16, Issue:2

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone

1990
[Giant cell arteritis of the aortic arch. An review with reference to a case report].
    Tijdschrift voor gerontologie en geriatrie, 1987, Volume: 18, Issue:5

    Topics: Aged; Angiography; Aorta, Thoracic; Female; Giant Cell Arteritis; Humans; Prednisone

1987
Temporal arteritis and renal disease. Case report and review of the literature.
    The American journal of medicine, 1985, Volume: 78, Issue:1

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Kidney Diseases; Prednisone

1985
Polymyalgia rheumatica.
    Seminars in arthritis and rheumatism, 1972,Winter, Volume: 1, Issue:3

    Topics: Adult; Aged; Arteritis; Biopsy; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Art

1972
[Polymyalgia rheumatica (comprehensive review)].
    Fysiatricky a reumatologicky vestnik, 1973, Volume: 51, Issue:4

    Topics: Age Factors; Aspirin; Blood Protein Electrophoresis; Blood Sedimentation; Diagnosis, Differential; G

1973

Trials

27 trials available for prednisone and Aortic Arteritis, Giant Cell

ArticleYear
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.
    Rheumatology (Oxford, England), 2022, 07-06, Volume: 61, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone; Treatm

2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Annals of the rheumatic diseases, 2022, Volume: 81, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Double-Blind Method; Giant Cell Arteritis; Glucocorticoids; Human

2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    JAMA, 2022, 09-20, Volume: 328, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc

2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    JAMA, 2022, 09-20, Volume: 328, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc

2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    JAMA, 2022, 09-20, Volume: 328, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc

2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    JAMA, 2022, 09-20, Volume: 328, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc

2022
Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis.
    International journal of rheumatic diseases, 2019, Volume: 22, Issue:10

    Topics: Administration, Oral; Aged; Biomarkers; Delayed-Action Preparations; Dose-Response Relationship, Dru

2019
Ustekinumab for the Treatment of Giant Cell Arteritis.
    Arthritis care & research, 2021, Volume: 73, Issue:6

    Topics: Aged; Anti-Inflammatory Agents; Boston; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glu

2021
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
    Seminars in arthritis and rheumatism, 2021, Volume: 51, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone

2021
Treatment failure in giant cell arteritis.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:11

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Therapy, Combination; Female; Gi

2021
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
Trial of Tocilizumab in Giant-Cell Arteritis.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug The

2017
A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.
    International journal of rheumatic diseases, 2018, Volume: 21, Issue:1

    Topics: Delayed-Action Preparations; Drug Administration Schedule; Drug Compounding; Feasibility Studies; Fe

2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
    European journal of internal medicine, 2018, Volume: 57

    Topics: Aged; Antibodies, Monoclonal, Humanized; Aortitis; C-Reactive Protein; Drug Administration Schedule;

2018
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
    Arthritis research & therapy, 2019, 02-20, Volume: 21, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Therapy

2019
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
    Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:8

    Topics: Acute-Phase Proteins; Antibodies, Monoclonal, Humanized; Blood Sedimentation; C-Reactive Protein; Do

2019
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:12

    Topics: Adalimumab; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Do

2014
Endothelial function and carotid intima-media thickness in giant-cell arteritis.
    European journal of clinical investigation, 2014, Volume: 44, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blood Flow Velocity; Brachial Artery; Carotid Art

2014
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
    Annals of the rheumatic diseases, 2013, Sep-01, Volume: 72, Issue:9

    Topics: Aged; Aged, 80 and over; Down-Regulation; Female; Forkhead Transcription Factors; Gene Expression Re

2013
Steroid-responsive charles bonnet syndrome in temporal arteritis.
    The Journal of neuropsychiatry and clinical neurosciences, 2004,Fall, Volume: 16, Issue:4

    Topics: Aged; Biopsy; Brain; Electroencephalography; Female; Giant Cell Arteritis; Hallucinations; Humans; M

2004
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method

2006
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
    Annals of internal medicine, 2007, May-01, Volume: 146, Issue:9

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Blood Sedimentation; C-Reactive Protein; Dou

2007
Methotrexate treatment in the management of giant cell arteritis.
    Scandinavian journal of rheumatology, 1994, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Meth

1994
Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss.
    British journal of rheumatology, 1994, Volume: 33, Issue:4

    Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Bone Density; Drug Administration Schedule; Etidro

1994
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    Annals of the rheumatic diseases, 1996, Volume: 55, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug A

1996
The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis.
    Scandinavian journal of rheumatology, 1998, Volume: 27, Issue:2

    Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Body Composition; Body Mass Index; Body Weight; Double

1998
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
    Annals of internal medicine, 2001, Jan-16, Volume: 134, Issue:2

    Topics: Adrenal Cortex Hormones; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Comb

2001
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    The Journal of rheumatology, 2001, Volume: 28, Issue:11

    Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone

2001
Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Drug Resistance; Drug Therapy, Com

2002
Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study.
    Annals of internal medicine, 1975, Volume: 82, Issue:5

    Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Prospective Studi

1975
[Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].
    Annales de medecine interne, 1992, Volume: 143, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Giant Cell

1992

Other Studies

445 other studies available for prednisone and Aortic Arteritis, Giant Cell

ArticleYear
Giant cell arteritis with spontaneous remission.
    Modern rheumatology case reports, 2022, Jan-07, Volume: 6, Issue:1

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; Remission, Spontaneo

2022
Polymyalgia rheumatica.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021, 11-22, Volume: 193, Issue:46

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Hum

2021
Giant cell arteritis treatment patterns and rates of serious infections.
    Clinical and experimental rheumatology, 2022, Volume: 40, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Female; Frailty; Giant Cell Arteritis; Humans; Immunosuppressive Agents

2022
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica.
    Clinical and experimental medicine, 2023, Volume: 23, Issue:7

    Topics: Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone;

2023
Development of a web tool to calculate the cumulative dose of glucocorticoids.
    Reumatologia clinica, 2023, Volume: 19, Issue:1

    Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednisone

2023
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
    Seminars in arthritis and rheumatism, 2023, Volume: 59

    Topics: Carotid Arteries; Constriction, Pathologic; Female; Giant Cell Arteritis; Humans; Hypertension; Male

2023
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.
    RMD open, 2023, Volume: 9, Issue:2

    Topics: Giant Cell Arteritis; Humans; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome

2023
Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study.
    Rheumatology international, 2023, Volume: 43, Issue:7

    Topics: Aged; Chronic Disease; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methylprednisolo

2023
[Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Der Internist, 2019, Volume: 60, Issue:10

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Giant Cell Arteritis; Giant C

2019
Embouchure Claudication: A Trumpeter's Unique Presentation of Giant Cell Arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2019, Volume: 39, Issue:4

    Topics: Administration, Oral; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Drug Therapy, Combinatio

2019
Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2020, Volume: 40, Issue:1

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Giant Cell Art

2020
Tunnel Vision in a Patient with Polymyalgia Rheumatica.
    The Journal of rheumatology, 2020, Volume: 47, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Biopsy; Fibrosis; Follow-Up Studies; Giant Cell Arteritis; Humans; Ma

2020
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study.
    Seminars in arthritis and rheumatism, 2020, Volume: 50, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Case-Control Studies; Dose-Response Relationship, Drug; Female; Gian

2020
Autoimmune Conditions: Polymyalgia Rheumatica and Dermatomyositis.
    FP essentials, 2020, Volume: 494

    Topics: Dermatomyositis; Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia

2020
Timing of cataract surgery in patients with giant cell arteritis.
    Journal of cataract and refractive surgery, 2021, Jan-01, Volume: 47, Issue:1

    Topics: Aged; Cataract; Female; Giant Cell Arteritis; Humans; Optic Neuropathy, Ischemic; Prednisone; Retros

2021
The U.S. Veterans Health Administration national giant cell arteritis (GCA) database cohort: incident ophthalmic complications in biopsy-negative GCA patients.
    Clinical rheumatology, 2021, Volume: 40, Issue:7

    Topics: Biopsy; Giant Cell Arteritis; Humans; Prednisone; Retrospective Studies; Temporal Arteries; Veterans

2021
The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2021, Sep-01, Volume: 41, Issue:3

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Biopsy; Combined Modality Therapy; Cost-

2021
Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
    The American journal of medicine, 2017, Volume: 130, Issue:8

    Topics: Aged; Aged, 80 and over; Aorta; Carotid Arteries; Comorbidity; Female; Femoral Artery; Fluorodeoxygl

2017
A Woman With a Spot in Her Vision.
    JAMA ophthalmology, 2017, 09-01, Volume: 135, Issue:9

    Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Infarction; Nerve Fibers; Predn

2017
[Bilateral acute arteritic anterior ischemic optic neuropathy during chronic steroid therapy].
    Journal francais d'ophtalmologie, 2017, Volume: 40, Issue:7

    Topics: Aged, 80 and over; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Optic Neuropathy, Ischemic;

2017
Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    The Journal of rheumatology, 2017, Volume: 44, Issue:12

    Topics: Aged; Aged, 80 and over; Brain; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle

2017
Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
    Internal medicine journal, 2017, Volume: 47, Issue:10

    Topics: Aged, 80 and over; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; Stroke

2017
An Unusual Cause of Leg Pain.
    The New England journal of medicine, 2017, Nov-16, Volume: 377, Issue:20

    Topics: Aged; Biopsy; Carotid Arteries; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dru

2017
[Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].
    La Revue de medecine interne, 2018, Volume: 39, Issue:2

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Female; France; Giant Cell Arteritis; Gl

2018
Non-infective endocarditis: Expanding the phenotype of giant cell arteritis.
    Joint bone spine, 2019, Volume: 86, Issue:1

    Topics: Aged, 80 and over; Aorta; Endocarditis, Non-Infective; Female; Giant Cell Arteritis; Glucocorticoids

2019
Foreword: clinical challenges of diagnosing and managing giant cell arteritis.
    Rheumatology (Oxford, England), 2018, 02-01, Volume: 57, Issue:suppl_2

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Disease Management; Drug Therapy, Combi

2018
A case of Hickam's dictum in a presenting third nerve palsy.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2018, Volume: 53, Issue:4

    Topics: Aged; Blepharoptosis; C-Reactive Protein; Computed Tomography Angiography; Diplopia; Female; Giant C

2018
[Kaposi's sarcoma in a steroid-treated temporal arteritis].
    Atencion primaria, 2019, Volume: 51, Issue:4

    Topics: Aged, 80 and over; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Leg; Prednisone; Sarcoma,

2019
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
    The Journal of rheumatology, 2019, Volume: 46, Issue:5

    Topics: Academic Medical Centers; Aged; Biopsy, Needle; Case-Control Studies; Dose-Response Relationship, Dr

2019
Giant Cell Arteritis Presenting with a Tongue Lesion.
    The American journal of medicine, 2019, Volume: 132, Issue:5

    Topics: Aged, 80 and over; Biopsy; Deglutition Disorders; Diagnosis, Differential; Female; Gastrostomy; Gian

2019
Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study.
    Seminars in arthritis and rheumatism, 2019, Volume: 49, Issue:2

    Topics: Age Factors; Aged, 80 and over; Case-Control Studies; Female; Giant Cell Arteritis; Glucocorticoids;

2019
Determinants of Positive Temporal Artery Biopsies in the Veterans Health Administration National Database Cohort.
    Arthritis care & research, 2020, Volume: 72, Issue:5

    Topics: Aged; Aged, 80 and over; Biopsy; Databases, Factual; Female; Giant Cell Arteritis; Glucocorticoids;

2020
Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
    The Journal of rheumatology, 2019, Volume: 46, Issue:5

    Topics: Case-Control Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Predniso

2019
Will imaging change the diagnosis and management of giant cell arteritis?
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2019, Dec-01, Volume: 57, Issue:4

    Topics: Aged, 80 and over; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Male; Prednisone; Ultraso

2019
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: 'Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone' by Samson and Bonnotte.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Cross-Sectional Studies; Giant Cell Arteritis; Humans; Infections

2020
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Humans; Infections; Interleukin-6; Predniso

2020
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
    Frontiers in immunology, 2019, Volume: 10

    Topics: Acute-Phase Proteins; Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthr

2019
Refractory giant cell arteritis on prednisone and tocilizumab: improvement with subsequent tuberculosis reactivation.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2019, Volume: 54, Issue:4

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Fatal Outcome; Fema

2019
Giant cell arteritis: a multicenter observational study in Brazil.
    Clinics (Sao Paulo, Brazil), 2013, Volume: 68, Issue:3

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Biopsy; Brazil; Female; Giant Cell Arteritis; Humans;

2013
[Giant cell arteritis].
    Praxis, 2013, Jun-05, Volume: 102, Issue:12

    Topics: Adrenal Cortex Hormones; Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell A

2013
Cytomegalovirus esophagitis precipitated with immunosuppression in elderly giant cell arteritis patients.
    Aging clinical and experimental research, 2013, Volume: 25, Issue:2

    Topics: Aged; Aged, 80 and over; Cytomegalovirus Infections; Esophagitis; Female; Giant Cell Arteritis; Gluc

2013
Polymyalgia rheumatica and giant cell arteritis: how best to approach these related diseases.
    The Journal of family practice, 2013, Volume: 62, Issue:6 Suppl

    Topics: Anti-Inflammatory Agents; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Human

2013
Pallid disc edema and choroidal perfusion delay in posthemodialysis nonarteritic ischemic optic neuropathy.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2013, Volume: 48, Issue:5

    Topics: Choroid; Fluorescein Angiography; Giant Cell Arteritis; Glucocorticoids; Humans; Kidney Failure, Chr

2013
Giant cell arteritis and disseminated tuberculosis: presentation of two cases.
    Scandinavian journal of rheumatology, 2013, Volume: 42, Issue:6

    Topics: Aged; Antitubercular Agents; Biopsy; Diagnosis, Differential; Female; Fever of Unknown Origin; Giant

2013
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.
    Seminars in arthritis and rheumatism, 2014, Volume: 43, Issue:6

    Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors;

2014
Use of herbal supplements with undeclared drug ingredients masking giant cell arteritis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:1

    Topics: Back Pain; Biopsy; Delayed Diagnosis; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Ag

2014
Bilateral axillary arterial obstruction.
    BMJ case reports, 2014, Jan-22, Volume: 2014

    Topics: Aged; Arterial Occlusive Diseases; Atherosclerosis; Axillary Artery; Diagnosis, Differential; Female

2014
Subacute visual loss and bilateral fixed mydriasis: an atypical case of giant cell arteritis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:8

    Topics: Aged; Blindness; Female; Ganglia, Parasympathetic; Giant Cell Arteritis; Humans; Ischemia; Methylpre

2014
Temporal artery enhancement on cranial magnetic resonance imaging.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2014, Volume: 49, Issue:3

    Topics: Administration, Oral; Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Female;

2014
Tongue necrosis: an unusual clinical presentation of giant cell arteritis.
    Arthritis & rheumatology (Hoboken, N.J.), 2014, Volume: 66, Issue:10

    Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Methylprednisolone; Necrosis; Prednison

2014
Transient visual loss due to reversible 'pending' central retinal artery occlusion in occult giant cell arteritis.
    Eye (London, England), 2014, Volume: 28, Issue:11

    Topics: Administration, Oral; Biopsy; Blindness; Blood Sedimentation; C-Reactive Protein; Carotid Artery, In

2014
Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients.
    Medicine, 2014, Volume: 93, Issue:5

    Topics: Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Drug

2014
In-hospital delirium while awaiting temporal artery biopsy: a teachable moment.
    JAMA internal medicine, 2014, Volume: 174, Issue:12

    Topics: Aged; Analgesics, Opioid; Anti-Inflammatory Agents; Baclofen; Biopsy; Delirium; Diagnosis, Different

2014
Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.
    The Journal of rheumatology, 2015, Volume: 42, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; France; Giant Cell Arteritis; Humans; Hyd

2015
Severe strongyloidiasis with negative serology after corticosteroid treatment.
    The American journal of case reports, 2015, Feb-18, Volume: 16

    Topics: Aged; Giant Cell Arteritis; Glucocorticoids; Humans; Immunocompromised Host; Male; Prednisone; Risk

2015
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.
    Rheumatology (Oxford, England), 2015, Volume: 54, Issue:9

    Topics: Aged; Aged, 80 and over; Biomarkers; Biopsy; Case-Control Studies; Cytokines; Female; Giant Cell Art

2015
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
    The Journal of rheumatology, 2015, Volume: 42, Issue:7

    Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumati

2015
No medicine is sometimes the best medicine.
    BMJ case reports, 2015, May-14, Volume: 2015

    Topics: Aged; Anti-Bacterial Agents; Cough; Fatigue; Female; Giant Cell Arteritis; Hospitalization; Humans;

2015
Tongue necrosis in giant-cell arteritis.
    QJM : monthly journal of the Association of Physicians, 2015, Volume: 108, Issue:10

    Topics: Aged; Biopsy; Diphosphonates; Female; Giant Cell Arteritis; Humans; Methotrexate; Necrosis; Predniso

2015
Concomitant giant cell arteritis and secondary adrenal insufficiency.
    Scandinavian journal of rheumatology, 2015, Volume: 44, Issue:6

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aged; Biopsy; Comorbidity; Endocrine System Dise

2015
What to do when the Diagnosis of Giant Cell Arteritis and Takayasu's Arteritis Overlap.
    The Israel Medical Association journal : IMAJ, 2015, Volume: 17, Issue:2

    Topics: Aged; Angiography; Axillary Artery; Blood Sedimentation; Brachial Artery; Female; Giant Cell Arterit

2015
Enhancement of the optic nerve sheath and temporal arteries from giant cell arteritis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2015, Volume: 50, Issue:5

    Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Optic Nerve

2015
Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
    Arthritis & rheumatology (Hoboken, N.J.), 2016, Volume: 68, Issue:5

    Topics: Aftercare; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Asymptomatic Diseases; Cyclo

2016
Coronary arteritis: An entity to be considered in giant cell arteritis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2016, Volume: 51, Issue:1

    Topics: Aged; Aortitis; Coronary Artery Disease; Fatal Outcome; Female; Giant Cell Arteritis; Glucocorticoid

2016
Magnetic resonance imaging findings in giant cell arteritis.
    Eye (London, England), 2016, Volume: 30, Issue:5

    Topics: Administration, Oral; Aged, 80 and over; Biopsy; Blood Sedimentation; C-Reactive Protein; Giant Cell

2016
An Older Adult with Headache and Visual Blurring.
    Journal of emergency nursing, 2016, Volume: 42, Issue:4

    Topics: Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Giant Cell Arteritis; Headache; Humans; M

2016
Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.
    Journal of clinical immunology, 2016, Volume: 36, Issue:4

    Topics: Agammaglobulinemia; Aged; Aged, 80 and over; B-Lymphocyte Subsets; Female; Giant Cell Arteritis; Glu

2016
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study.
    Medicine, 2016, Volume: 95, Issue:19

    Topics: Aged; Aged, 80 and over; Biopsy; Disease Progression; Female; Fever; Follow-Up Studies; Giant Cell A

2016
Involvement and prognosis value of CD8(+) T cells in giant cell arteritis.
    Journal of autoimmunity, 2016, Volume: 72

    Topics: Aged; Aged, 80 and over; CD8-Positive T-Lymphocytes; Cells, Cultured; Chemokine CXCL10; Chemokine CX

2016
When a temporal artery biopsy reveals a diagnosis other than temporal arteritis: eosinophilic granulomatosis with polyangiitis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2016, Volume: 51, Issue:3

    Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy; Churg-Strauss Syndrome; Cyclophosphamide; Diagnosis,

2016
Giant Cell Arteritis: Visual Loss Is Our Major Concern.
    The Journal of rheumatology, 2016, Volume: 43, Issue:8

    Topics: Giant Cell Arteritis; Humans; Prednisone; Vision Disorders

2016
Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
    The Journal of rheumatology, 2017, Volume: 44, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Denmark; Diabetes Mellitus; Female; Giant Cell Arteriti

2017
Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2017, Volume: 30, Issue:6

    Topics: Aged; Aged, 80 and over; Biopsy; Female; Fibrosis; Giant Cell Arteritis; Glucocorticoids; Humans; Ma

2017
[Mesenteric artery involvement in giant cell arteritis: two cases and literature review].
    La Revue de medecine interne, 2008, Volume: 29, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aorta, Abdominal; Aortitis; Arteritis; Aspirin; B

2008
Development of autoimmune diseases after vaccination.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:4

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Giant Cell Arteritis;

2008
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:3

    Topics: Biopsy; Cerebral Veins; Female; Giant Cell Arteritis; Humans; Inflammation; International Normalized

2008
Case records of the Massachusetts General Hospital. Case 36-2008. A 59-year-old man with chronic daily headache.
    The New England journal of medicine, 2008, Nov-20, Volume: 359, Issue:21

    Topics: Brain; Chronic Disease; Diagnosis, Differential; Dura Mater; Fever; Giant Cell Arteritis; Glucocorti

2008
[80-year-old woman without noteworthy preconditions: 4 weeks of facial and temporal pain. Horton's arteritis].
    MMW Fortschritte der Medizin, 2008, Oct-23, Volume: 150, Issue:43

    Topics: Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Diagnosis, Differential; Facial Pain; Fe

2008
[Scalp necrosis revealing Horton's disease].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:12

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Necrosis

2008
High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment.
    Annals of the rheumatic diseases, 2009, Volume: 68, Issue:2

    Topics: Biomarkers; Chromogranin A; Female; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans

2009
[18F]FDG PET/CT in the diagnosis of large vessel vasculitis.
    Internal medicine journal, 2009, Volume: 39, Issue:4

    Topics: Aged; Aorta; Aortitis; Blood Vessel Prosthesis Implantation; Coronary Artery Bypass; Fatal Outcome;

2009
Headaches due to giant cell arteritis following herpes zoster ophthalmicus in an elderly patient.
    Cephalalgia : an international journal of headache, 2010, Volume: 30, Issue:2

    Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Female; Giant Cell Arteritis; Headach

2010
68-year-old woman with confusion.
    Mayo Clinic proceedings, 2009, Volume: 84, Issue:8

    Topics: Aged; Confusion; Delirium; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administr

2009
Temporal artery vasculitis in young: a report of two cases.
    Rheumatology international, 2010, Volume: 30, Issue:10

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Giant Cell Arteritis; HIV Infections;

2010
Scalp necrosis in giant cell arteritis in an African-Colombian patient.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009, Volume: 15, Issue:6

    Topics: Aged; Anti-Inflammatory Agents; Black People; Colombia; Giant Cell Arteritis; Humans; Male; Necrosis

2009
A confusing patient's history: small or large vessel vasculitis?
    Rheumatology international, 2010, Volume: 30, Issue:12

    Topics: Autoantibodies; Azathioprine; Conjunctivitis; Cyclophosphamide; Diagnosis, Differential; Drug Therap

2010
Case of the missed opportunity for temporal artery biopsy.
    The Journal of the Arkansas Medical Society, 2009, Volume: 106, Issue:4

    Topics: Aged, 80 and over; Appointments and Schedules; Biopsy; Diagnostic Errors; Female; Giant Cell Arterit

2009
Tongue infarction as first symptom of temporal arteritis.
    Rheumatology international, 2012, Volume: 32, Issue:3

    Topics: Aged; Debridement; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Infarction; Necrosis; Pred

2012
By the way, doctor. I have been diagnosed with temporal arteritis and am being treated with a drug called prednisone, which the doctor says is a steroid. I know athletes use steroids to bulk up, and I can't see how that would have anything to do with temp
    Harvard health letter, 2009, Volume: 35, Issue:1

    Topics: Anabolic Agents; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone; Sports

2009
Giant cell arteritis and bilateral peroneal nerve palsy.
    Scandinavian journal of rheumatology, 2010, Volume: 39, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Electrodiagnosis; Female; Giant Cell Arteritis; Humans; Neural Condu

2010
Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:2

    Topics: Biopsy; Drug Therapy, Combination; Genetic Predisposition to Disease; Genotype; Giant Cell Arteritis

2010
Taking PET for a walk - an unusual cause of bilateral leg claudication.
    The Journal of rheumatology, 2010, Volume: 37, Issue:4

    Topics: Alendronate; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Female; Giant Cell Arteri

2010
[Dutch College of General Practitioner's practice guideline on polymyalgia rheumatica and temporal arteritis].
    Nederlands tijdschrift voor geneeskunde, 2010, Volume: 154

    Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Family Practice; Giant Cell Arteritis; Humans; Ne

2010
Evaluation for clinical predictors of positive temporal artery biopsy in giant cell arteritis.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anorexia; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential;

2011
A 78-year-old woman with bilateral tongue necrosis.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 111, Issue:1

    Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Necr

2011
Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series.
    Arthritis care & research, 2011, Volume: 63, Issue:5

    Topics: Aged; Aged, 80 and over; Biopsy; Bronchoalveolar Lavage Fluid; Critical Care; Female; Giant Cell Art

2011
Clinical images: Necrosis at the tip of the nose in an 83-year-old man.
    Arthritis and rheumatism, 2011, Volume: 63, Issue:6

    Topics: Aged, 80 and over; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Male; Methylprednisolone;

2011
Web of confusion.
    The American journal of medicine, 2011, Volume: 124, Issue:6

    Topics: Anti-Inflammatory Agents; Aortic Dissection; Aortic Rupture; Aortitis; Autopsy; Diagnosis, Different

2011
Interactive medical case. A sleeping giant.
    The New England journal of medicine, 2011, Jun-16, Volume: 364, Issue:24

    Topics: Abdominal Pain; Aged; Aortitis; Diagnosis, Differential; Female; Fever; Giant Cell Arteritis; Glucoc

2011
Acute inflammatory aortitis: utility of hybrid imaging with positron emission tomography/computed tomography in diagnosis and follow-up.
    European heart journal. Cardiovascular Imaging, 2012, Volume: 13, Issue:2

    Topics: Acute Disease; Aortitis; Azathioprine; Biopsy; Drug Therapy, Combination; Female; Fluorodeoxyglucose

2012
Giant cell arteritis as a cause of acute myocarditis in the elderly.
    The Journal of rheumatology, 2011, Volume: 38, Issue:11

    Topics: Acute Disease; Aged, 80 and over; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Myocarditis

2011
Giant cell arteritis in Mexican patients.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:1

    Topics: Aged; Aged, 80 and over; Amaurosis Fugax; Antirheumatic Agents; Blindness; Ethnicity; Female; Follow

2012
Role of oral cyclophosphamide in the treatment of giant cell arteritis.
    Rheumatology (Oxford, England), 2012, Volume: 51, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Cyclophosphamide; Dose-Response Relationship, Drug; D

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis care & research, 2012, Volume: 64, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug;

2012
Giant cell arteritis followed by idiopathic retroperitoneal fibrosis in the same patient--an unexpected positron emission tomography finding.
    Rheumatology (Oxford, England), 2012, Volume: 51, Issue:9

    Topics: Aged; Aorta; Giant Cell Arteritis; Glucocorticoids; Humans; Hydronephrosis; Incidental Findings; Mag

2012
Initial neuro-ophthalmological manifestations in Churg-Strauss syndrome.
    BMJ case reports, 2010, Oct-12, Volume: 2010

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Churg-Strauss Syndrome; Cyclophosphamide; Diplopia; Drug

2010
Recovery of vision from no light perception in giant cell arteritis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:8

    Topics: Administration, Oral; Aged; Biopsy; Blindness; Female; Fluorescein Angiography; Giant Cell Arteritis

2012
Modified reduction aortoplasty with external reinforcement of the ascending aortic aneurysm caused by giant cell arteritis treated as polymyalgia rheumatica.
    General thoracic and cardiovascular surgery, 2013, Volume: 61, Issue:4

    Topics: Aged; Aorta; Aortic Aneurysm; Aortic Valve; Aortic Valve Insufficiency; Female; Giant Cell Arteritis

2013
Florid arteritis confined to a single branch of the superficial temporal artery.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:10

    Topics: Aged; Biopsy; Blood Sedimentation; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone

2012
Bilateral optic perineuritis as the presenting feature of giant cell arteritis.
    BMJ case reports, 2013, Jan-29, Volume: 2013

    Topics: Aged; Anti-Inflammatory Agents; Facial Dermatoses; Giant Cell Arteritis; Humans; Jaw Diseases; Magne

2013
Best catch from NANOSNET.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2002, Volume: 22, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Exercise; Female; Giant Cell Arte

2002
Giant cell arteritis complicated by spinal cord infarction: a therapeutic dilemma.
    The Journal of rheumatology, 2002, Volume: 29, Issue:7

    Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap

2002
Deflazacort in giant cell arteritis.
    The Journal of rheumatology, 2002, Volume: 29, Issue:10

    Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcifediol; Dietary Supplements;

2002
[Management of visual loss secondary to giant cell arteritis].
    Archivos de la Sociedad Espanola de Oftalmologia, 2002, Volume: 77, Issue:12

    Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone; Vision, Low

2002
Meningoradiculitis associated with giant cell arteritis.
    Neurology, 2002, Dec-10, Volume: 59, Issue:11

    Topics: Anti-Inflammatory Agents; Azathioprine; Cranial Nerve Diseases; Cyclophosphamide; Giant Cell Arterit

2002
Temporal arteritis presenting with scalp ulceration.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2002, Volume: 16, Issue:6

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Female; Giant Cell Arteritis; Humans; Prednisone; Scalp D

2002
[Giant cell arteritis after the age of 75].
    Annales de medecine interne, 2002, Volume: 153, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Drug Monitoring; F

2002
[Chronic cough and fever at the onset of giant cell arteritis].
    Archivos de bronconeumologia, 2003, Volume: 39, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Cough; Female; Fever; Giant Cell Arteriti

2003
Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:4

    Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Sch

2003
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:4

    Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Sch

2003
Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodies.
    European neurology, 2003, Volume: 49, Issue:4

    Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Cardiolipins; Diabetes Mellitus; Diagnosis,

2003
Visual prognosis in extremely old patients with temporal (giant cell) arteritis.
    Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:5

    Topics: Aged; Aged, 80 and over; Female; Giant Cell Arteritis; Humans; Male; Methylprednisolone; Prednisone;

2003
Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2003, Volume: 23, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Administration Schedule; Fundus Oculi; Giant

2003
Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    The Journal of rheumatology, 2003, Volume: 30, Issue:6

    Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Fever of Unknown Origin; G

2003
Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy.
    Journal of the American Medical Association, 1957, Mar-09, Volume: 163, Issue:10

    Topics: Adrenal Cortex Hormones; Arteritis; Biopsy; Cortisone; Giant Cell Arteritis; Prednisone

1957
[Arteritis temporalis].
    Nordisk medicin, 1963, Mar-14, Volume: 69

    Topics: Giant Cell Arteritis; Humans; Prednisone; Temporal Muscle

1963
[ARTERITIS TEMPORALIS].
    Belgisch tijdschrift voor geneeskunde, 1964, Jan-15, Volume: 20

    Topics: Adrenocorticotropic Hormone; Arteritis; Cortisone; Diagnosis, Differential; Geriatrics; Giant Cell A

1964
POLYMYALGIA RHEUMATICA--AN ESSAY IN DISCIPLESHIP.
    Journal of the Irish Medical Association, 1964, Volume: 54

    Topics: Giant Cell Arteritis; Humans; Muscular Diseases; Polymyalgia Rheumatica; Prednisone; Rheumatic Disea

1964
[POLYMYALGIA RHEUMATICA. REVIEW AND PERSONAL CASES].
    Ugeskrift for laeger, 1964, Aug-20, Volume: 126

    Topics: Adrenocorticotropic Hormone; Arthritis; Blood Protein Electrophoresis; Diagnosis, Differential; Elec

1964
TEMPORAL ARTERITIS; A RARITY IN THE YOUNG ADULT.
    Archives of internal medicine, 1964, Volume: 114

    Topics: Biopsy; Dexamethasone; Drug Therapy; Giant Cell Arteritis; Headache; Humans; Lidocaine; Prednisone

1964
TEMPORAL ARTERITIS.
    The Practitioner, 1965, Volume: 194

    Topics: Blindness; Clinical Laboratory Techniques; Drug Therapy; Eye Manifestations; Geriatrics; Giant Cell

1965
PERIOSTITIS DUE TO GIANT-CELL ARTERITIS.
    Annals of physical medicine, 1965, Volume: 8

    Topics: Arteritis; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Therapy; Geriatrics; Gian

1965
[ARTERITIS TEMPORALIS].
    Nederlands tijdschrift voor geneeskunde, 1965, Aug-07, Volume: 109

    Topics: Arteritis; Drug Therapy; Geriatrics; Giant Cell Arteritis; Humans; Prednisone

1965
[A case of temporal arteritis treated successfully with aureomycin and prednisone].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1962, May-14, Volume: 17

    Topics: Arteritis; Chlortetracycline; Giant Cell Arteritis; Prednisone

1962
[An 80-year-old patient with known polymyalgia, worsening of general condition and weight loss].
    Praxis, 2003, Sep-10, Volume: 92, Issue:37

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Giant Ce

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Arthritis and rheumatism, 2003, Oct-15, Volume: 49, Issue:5

    Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation

2003
[Brain nocardiasis of good outcome occurring in a heart transplant recipient].
    La Revue de medecine interne, 2003, Volume: 24, Issue:11

    Topics: Adrenal Cortex Hormones; Brain Abscess; Giant Cell Arteritis; Heart Transplantation; Humans; Immunoc

2003
Concomitant giant cell aortitis, thoracic aortic aneurysm, and aortic arch syndrome: occurrence in a patient and significance.
    Arthritis and rheumatism, 2003, Dec-15, Volume: 49, Issue:6

    Topics: Aged; Aortic Aneurysm, Thoracic; Aortic Arch Syndromes; Female; Giant Cell Arteritis; Glucocorticoid

2003
Colour duplex ultrasonography in the management of giant cell arteritis.
    Clinical rheumatology, 2003, Volume: 22, Issue:6

    Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Giant Cell

2003
Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
    Rheumatology (Oxford, England), 2004, Volume: 43, Issue:3

    Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Chi-Square Distribution; Cytokines; Female; Giant Cel

2004
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
    The American journal of medicine, 2004, Jan-01, Volume: 116, Issue:1

    Topics: Aged; Aortitis; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell A

2004
Re: Guidelines for the diagnosis and management of PMR/GCA.
    Age and ageing, 2004, Volume: 33, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; P

2004
Acute stress masking the biochemical phenotype of partial androgen insensitivity syndrome in a patient with a novel mutation in the androgen receptor.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:3

    Topics: Androgen-Insensitivity Syndrome; Binding Sites; Giant Cell Arteritis; Glucocorticoids; Gonadal Stero

2004
Initiation of glucocorticoid therapy: before or after temporal artery biopsy?
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Blood Sedimentation

2004
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Blindness; Drug Therapy, Combination; Fe

2004
A "negative" temporal artery biopsy, positive for arteritis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:7

    Topics: Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocortico

2004
Giant cell arteritis: a new association with benign paroxysmal positional vertigo.
    The Laryngoscope, 2004, Volume: 114, Issue:8

    Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Middle Aged; Nystagmus, Pathologic; Prednisone; Semic

2004
Positron emission tomography in the diagnosis of giant cell arteritis.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:10

    Topics: Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arterit

2004
[Aortic dissection in temporal arteritis].
    La Revue de medecine interne, 2004, Volume: 25, Issue:11

    Topics: Aged; Aortic Aneurysm; Aortic Dissection; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Pre

2004
Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.
    Medicine, 2004, Volume: 83, Issue:6

    Topics: Aged; Arm; Arteriosclerosis; Blindness; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Ische

2004
Unusual presentations of giant cell arteritis (temporal arteritis).
    Internal medicine journal, 2004, Volume: 34, Issue:11

    Topics: Aged; Aged, 80 and over; Biopsy; Deglutition Disorders; Giant Cell Arteritis; Glucocorticoids; Human

2004
Magnetic resonance imaging in optic neuritis due to giant cell arteritis.
    Arthritis and rheumatism, 2005, Apr-15, Volume: 53, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dru

2005
Ruffled hair and fever in an old woman with Alzheimer's disease.
    Aging clinical and experimental research, 2005, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Cognition; Disease Progression

2005
Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Ophthalmology, 2005, Volume: 112, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Biopsy; Color Perception; Female; Giant Cell Arteriti

2005
[The devil exorcised by Beelzebub].
    MMW Fortschritte der Medizin, 2005, Jun-09, Volume: 147, Issue:23

    Topics: Aged; Burns; Diagnosis, Differential; Drug Eruptions; Giant Cell Arteritis; Humans; Male; Prednisone

2005
Uveitis as a presenting sign of giant cell arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2005, Volume: 25, Issue:3

    Topics: Aged; Biopsy; Blindness; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Optic Neuropathy, Is

2005
Optic neuropathy in giant cell arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2005, Volume: 25, Issue:3

    Topics: Acute Disease; Aged; Biopsy; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methylprednisolone

2005
A patient's diary.
    The New Zealand medical journal, 2005, Oct-28, Volume: 118, Issue:1224

    Topics: Aged; Anti-Inflammatory Agents; Blood Sedimentation; Giant Cell Arteritis; Humans; Male; Patient Par

2005
First-time manifestation of giant-cell arteritis during methotrexate treatment.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2005, Volume: 11, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Dose-Response Relationsh

2005
[Accelerated atheroma with prednisone and clopidogrel].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:3 Pt 1

    Topics: Aged; Atherosclerosis; Carotid Stenosis; Clopidogrel; Endarterectomy; Giant Cell Arteritis; Glucocor

2006
[Giant-cell arteritis].
    Medicina clinica, 2006, Apr-29, Volume: 126, Issue:16

    Topics: Biopsy; Clinical Trials as Topic; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone

2006
Bilateral choroidal ischemia in giant cell arteritis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:6

    Topics: Administration, Oral; Aged; Biopsy; Choroid; Female; Fluorescein Angiography; Giant Cell Arteritis;

2006
Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis. Identification of a relatively benign subgroup.
    Clinical rheumatology, 2007, Volume: 26, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Histocytochemistry;

2007
Giant cell arteritis--the methotrexate debate revisited.
    The Journal of rheumatology, 2006, Volume: 33, Issue:7

    Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blindness; Drug Therapy, Combination; Female; Giant

2006
[Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report].
    Klinika oczna, 2006, Volume: 108, Issue:1-3

    Topics: Blindness; Giant Cell Arteritis; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Prednisone;

2006
Transient cough-induced blindness in temporal arteritis.
    Neurology, 2006, Oct-24, Volume: 67, Issue:8

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Cough; Giant Cell Arteritis; Humans; Male; Prednisone; Te

2006
[Atypical presentation of a clinical case of giant cell arteritis].
    Anales de medicina interna (Madrid, Spain : 1984), 2006, Volume: 23, Issue:6

    Topics: Aged; Biopsy; Blood Sedimentation; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Hysterecto

2006
An 80-year-old man with a nonhealing glabellar lesion. Primary cutaneous nocardiosis.
    Archives of pathology & laboratory medicine, 2006, Volume: 130, Issue:10

    Topics: Accidental Falls; Aged, 80 and over; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressiv

2006
Masked giant cell arteritis.
    Australian family physician, 2006, Volume: 35, Issue:11

    Topics: Aged; Anemia; Anti-Inflammatory Agents; Biopsy; Blood Sedimentation; Female; Giant Cell Arteritis; H

2006
Giant cell arteritis: Involvement of intracranial arteries.
    Arthritis and rheumatism, 2006, Dec-15, Volume: 55, Issue:6

    Topics: Aged; Biopsy; Cerebral Angiography; Cerebral Infarction; Female; Giant Cell Arteritis; Glucocorticoi

2006
[MRI-based diagnosis of giant cell arteritis].
    Praxis, 2006, Dec-06, Volume: 95, Issue:49

    Topics: Aortitis; Biopsy; Diagnosis, Differential; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosu

2006
When arteries get inflamed. Headaches are the most common symptom of temporal arteritis, but the anemia, weight loss, and malaise it produces means other diseases are often suspected.
    Harvard health letter, 2006, Volume: 32, Issue:1

    Topics: Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Middle Aged; Prednisone

2006
[Induction therapy with corticoid pulses for treatment of temporal arteritis].
    Zeitschrift fur Rheumatologie, 2007, Volume: 66, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method

2007
Scalp necrosis in giant cell arteritis.
    The Journal of rheumatology, 2007, Volume: 34, Issue:2

    Topics: Administration, Oral; Aged; Female; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Necrosi

2007
Teaching case: severe headaches in an elderly patient.
    Headache, 2007, Volume: 47, Issue:1

    Topics: Aged; Biopsy; Brain; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Magnetic Resonance Ima

2007
Discussion of the pathology of giant cell arteritis.
    Headache, 2007, Volume: 47, Issue:1

    Topics: Aged; Biopsy; Brain; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Magnetic Resonance Ima

2007
Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:5

    Topics: Acute-Phase Reaction; Anti-Inflammatory Agents; Blood Sedimentation; C-Reactive Protein; Dose-Respon

2007
Summaries for patients. Adding infliximab to the treatment regimen for giant cell arteritis.
    Annals of internal medicine, 2007, May-01, Volume: 146, Issue:9

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Double-Blind Method; Drug Therapy, Combinati

2007
Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.
    The British journal of dermatology, 2007, Volume: 157, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Attitude to Health; Cohort Studies;

2007
Giant cell arteritis presenting with hemianopic visual field loss.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:3

    Topics: Aged; Biopsy; Blood Sedimentation; Drug Therapy, Combination; Female; Giant Cell Arteritis; Hemianop

2007
Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
    Medicine, 2007, Volume: 86, Issue:4

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blindness; Female; Giant Cell Arteritis; Gluco

2007
[Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
    Zeitschrift fur Rheumatologie, 2007, Volume: 66, Issue:6

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Double-Blind Method; Giant Cell Arteritis; Humans;

2007
[Fulminant alveolar hemorrhage: evolution of giant cell arteritis to ANCA-positive vasculitis?].
    La Revue de medecine interne, 2008, Volume: 29, Issue:3

    Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Bio

2008
Images in vascular medicine. Giant cell arteritis presenting with acute myocardial infarction.
    Vascular medicine (London, England), 2007, Volume: 12, Issue:4

    Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coronary Angio

2007
Atherosclerosis in patients with biopsy-proven giant cell arteritis.
    Arthritis and rheumatism, 2007, Dec-15, Volume: 57, Issue:8

    Topics: Aged; Atherosclerosis; Biopsy; Carotid Arteries; Case-Control Studies; Female; Giant Cell Arteritis;

2007
Update: an 81-year-old woman with temporal arteritis.
    JAMA, 2007, Dec-05, Volume: 298, Issue:21

    Topics: Aged, 80 and over; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone

2007
[Giant cell arteritis].
    Praxis, 2007, Nov-14, Volume: 96, Issue:46

    Topics: Aged; Blood Sedimentation; Diagnosis, Differential; Diagnostic Tests, Routine; Fatigue; Female; Gian

2007
[Tongue necrosis under corticosteroids].
    Revue de stomatologie et de chirurgie maxillo-faciale, 2008, Volume: 109, Issue:1

    Topics: Acyclovir; Aged; Antiviral Agents; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necrosis;

2008
Temporal arteritis: a dilemma in clinical and pathological diagnosis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2008, Volume: 43, Issue:1

    Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Blood Sedimentation; C-Reacti

2008
Acute stent thrombosis in a patient with giant cell arteritis.
    The Canadian journal of cardiology, 2008, Volume: 24, Issue:4

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Di

2008
Reversible vertebral artery stenosis following corticotherapy in giant cell arteritis.
    European neurology, 2008, Volume: 59, Issue:6

    Topics: Aged; Anticoagulants; Biopsy; Brain Infarction; Cerebellar Diseases; Drug Therapy, Combination; Gian

2008
Acute bilateral tongue necrosis--a case report.
    The British journal of oral & maxillofacial surgery, 2008, Volume: 46, Issue:8

    Topics: Acute Disease; Aged, 80 and over; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necrosis; P

2008
Polymyalgia rheumatica. A manifestation of systemic giant-cell arteritis.
    Annals of internal medicine, 1967, Volume: 66, Issue:1

    Topics: Aged; Arteritis; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Pr

1967
Giant-cell arteritis producing an aortic arch syndrome.
    Annals of internal medicine, 1967, Volume: 66, Issue:3

    Topics: Aged; Aortic Arch Syndromes; Biopsy; Female; Giant Cell Arteritis; Humans; Prednisone; Radiography;

1967
Active temporal arteritis as a contraindication to elective surgery with general anesthesia.
    American journal of ophthalmology, 1967, Volume: 64, Issue:3

    Topics: Aged; Anesthesia, General; Blindness; Carcinoma, Squamous Cell; Giant Cell Arteritis; Humans; Laryng

1967
[Recurrent pleurisy during temporal arteritis].
    Le Poumon et le coeur, 1967, Volume: 23, Issue:6

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Pleural Effusion; Prednisone

1967
Temporal arteritis developing in the course of sulfonamide therapy.
    JAMA, 1967, May-22, Volume: 200, Issue:8

    Topics: Aged; Biopsy; Blood Sedimentation; Giant Cell Arteritis; Humans; Male; Prednisone; Skin Manifestatio

1967
Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks.
    European neurology, 1984, Volume: 23, Issue:6

    Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Combin

1984
Serum beta 2-microglobulin in temporal arteritis.
    The Netherlands journal of medicine, 1982, Volume: 25, Issue:5

    Topics: Aged; beta 2-Microglobulin; Beta-Globulins; Giant Cell Arteritis; Humans; Middle Aged; Prednisone

1982
[Popliteal neuritis complicating temporal arteritis].
    Harefuah, 1981, Nov-15, Volume: 101, Issue:10

    Topics: Aged; Giant Cell Arteritis; Humans; Knee Joint; Neuritis; Peripheral Nervous System Diseases; Predni

1981
[Involvement of oculomotor nerves. A little-known complication of Horton's disease].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, Dec-16, Volume: 58, Issue:46

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Ophthalmoplegia; Prednisone

1982
Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.
    Arthritis and rheumatism, 1984, Volume: 27, Issue:9

    Topics: Aged; Blood Coagulation Factors; Blood Sedimentation; Choroiditis; Diagnosis, Differential; Female;

1984
[Arterial Doppler in Horton's disease. A prospective study of 24 cases].
    La Revue de medecine interne, 1984, Volume: 5, Issue:4

    Topics: Aged; Arterial Occlusive Diseases; Biopsy; Cerebral Arteries; Female; Giant Cell Arteritis; Humans;

1984
Polymyalgia rheumatica and giant cell arteritis.
    The Western journal of medicine, 1984, Volume: 141, Issue:1

    Topics: Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone

1984
Respiratory tract symptoms as a clue to giant cell arteritis.
    Annals of internal medicine, 1984, Volume: 101, Issue:5

    Topics: Aged; Cough; Female; Giant Cell Arteritis; Glossalgia; Hoarseness; Humans; Male; Middle Aged; Neck;

1984
Temporal arteritis: case and review.
    Journal of the Mississippi State Medical Association, 1984, Volume: 25, Issue:10

    Topics: Aged; Blood Sedimentation; Confusion; Giant Cell Arteritis; Headache; Humans; Prednisone

1984
Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
    Annals of the rheumatic diseases, 1984, Volume: 43, Issue:5

    Topics: Aged; Antigens; Blood Sedimentation; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; G

1984
Giant cell arteritis and its variants.
    European neurology, 1984, Volume: 23, Issue:6

    Topics: Aged; Aortic Arch Syndromes; Arterial Occlusive Diseases; Arteries; Cerebral Arterial Diseases; Diag

1984
[Case of temporal arteritis].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1984, Aug-01, Volume: 37, Issue:15

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisone

1984
Cranial arteritis. A twenty-year review of cases.
    Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:2

    Topics: Adult; Aged; Australia; Female; Giant Cell Arteritis; Headache; Humans; Male; Middle Aged; Polymyalg

1984
[Various forms of giant cell arteritis: diagnostic difficulties and significance of biopsies].
    Schweizerische medizinische Wochenschrift, 1983, Jul-30, Volume: 113, Issue:30

    Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Temporal Arteries

1983
Polymyalgia rheumatica.
    Comprehensive therapy, 1983, Volume: 9, Issue:9

    Topics: Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Age

1983
[Diagnosis ex juvantibus-- an observation on giant cell arteritis].
    Tijdschrift voor gerontologie en geriatrie, 1983, Volume: 14, Issue:6

    Topics: Aged; Biopsy; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Prednisone; Temporal

1983
[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
    Annales de medecine interne, 1984, Volume: 135, Issue:1

    Topics: Aged; Anemia, Hemolytic; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Iatrogeni

1984
Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids.
    Annals of ophthalmology, 1984, Volume: 16, Issue:3

    Topics: Adrenal Cortex Hormones; Aged; Drug Administration Schedule; Female; Fractures, Spontaneous; Giant C

1984
Visual evoked potentials as an aid in the diagnosis and treatment of temporal arteritis.
    Annals of ophthalmology, 1984, Volume: 16, Issue:4

    Topics: Aged; Evoked Potentials, Visual; Giant Cell Arteritis; Humans; Male; Prednisone

1984
Giant cell arteritis and normal pressure hydrocephalus. A case report.
    Italian journal of neurological sciences, 1984, Volume: 5, Issue:1

    Topics: Aged; Cerebrospinal Fluid Proteins; Cerebrospinal Fluid Shunts; Female; Giant Cell Arteritis; Humans

1984
Giant cell arteritis presenting as a bilateral stroke.
    Arthritis and rheumatism, 1984, Volume: 27, Issue:7

    Topics: Cerebrovascular Disorders; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Middle Age

1984
Jaw claudication. Its value as a diagnostic clue.
    Postgraduate medicine, 1983, Volume: 73, Issue:2

    Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Jaw Dise

1983
Bilateral blindness in temporal arteritis with skip areas.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1983, Volume: 101, Issue:3

    Topics: Aged; Blindness; Female; Giant Cell Arteritis; Humans; Prednisone

1983
A case of temporal arteritis.
    Documenta ophthalmologica. Advances in ophthalmology, 1983, Feb-28, Volume: 55, Issue:1-2

    Topics: Aged; Giant Cell Arteritis; Headache; Humans; Male; Middle Aged; Papilledema; Prednisone

1983
Giant cell arteritis. An additional cause for fever of unknown origin.
    Minnesota medicine, 1983, Volume: 66, Issue:1

    Topics: Fever of Unknown Origin; Giant Cell Arteritis; Humans; Prednisone

1983
[Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis].
    Revue du rhumatisme et des maladies osteo-articulaires, 1983, Volume: 50, Issue:4

    Topics: Aged; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone

1983
Temporal arteritis causing admission to hospital in Auckland.
    The New Zealand medical journal, 1980, May-14, Volume: 91, Issue:659

    Topics: Aged; Female; Giant Cell Arteritis; Hospitalization; Humans; Male; Middle Aged; New Zealand; Prednis

1980
Fatal neurological complications in temporal arteritis: an unusual case.
    Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:4

    Topics: Aged; Cranial Nerve Diseases; Female; Giant Cell Arteritis; Glossopharyngeal Nerve; Humans; Hypoglos

1982
Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis.
    The American journal of medicine, 1981, Volume: 71, Issue:2

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Immunosuppression Therapy; Kidney Transplantation; Neopl

1981
[Temporal arteritis].
    Nederlands tijdschrift voor geneeskunde, 1982, Jan-09, Volume: 126, Issue:2

    Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Prednisone; Prognosis; Temporal Arteries

1982
Steroid psychoses: case report and brief overview.
    The Journal of clinical psychiatry, 1982, Volume: 43, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Haloperidol; Humans; Predniso

1982
Treatment of polymyalgia rheumatica.
    Arthritis and rheumatism, 1982, Volume: 25, Issue:1

    Topics: Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone

1982
Retinopathy in temporal arteritis.
    Annals of ophthalmology, 1982, Volume: 14, Issue:7

    Topics: Biopsy; Female; Giant Cell Arteritis; Humans; Middle Aged; Prednisone; Retinal Diseases; Retinal Hem

1982
Polymyalgia rheumatica with diffuse cerebral disease responding rapidly to steroid therapy.
    Journal of neurology, neurosurgery, and psychiatry, 1982, Volume: 45, Issue:9

    Topics: Aged; Blood Sedimentation; Dementia; Diffuse Cerebral Sclerosis of Schilder; Electroencephalography;

1982
Giant cell arteritis and microangiopathic hemolytic anemia.
    The American journal of medicine, 1982, Volume: 73, Issue:6

    Topics: Aged; Ampicillin; Anemia, Hemolytic; Cyclophosphamide; Female; Giant Cell Arteritis; Humans; Isoniaz

1982
Ophthalmoplegia, ptosis, and miosis in temporal arteritis.
    Neurology, 1980, Volume: 30, Issue:10

    Topics: Aged; Blepharoptosis; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Middle Aged;

1980
Overdiagnosis of temporal arteritis.
    Southern medical journal, 1981, Volume: 74, Issue:10

    Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Prednisone

1981
Diagnostic errors in polymyalgia rheumatica and temporal arteritis.
    Southern medical journal, 1981, Volume: 74, Issue:10

    Topics: Diagnostic Errors; Giant Cell Arteritis; Humans; Male; Middle Aged; Pancoast Syndrome; Polymyalgia R

1981
Temporal arteritis: cerebrospinal fluid and brain scan abnormalities (case report).
    Journal of the American Geriatrics Society, 1980, Volume: 28, Issue:3

    Topics: Cerebrovascular Disorders; Diagnosis, Differential; Giant Cell Arteritis; Humans; Male; Middle Aged;

1980
Aortic valve replacement for severe aortic regurgitation caused by idiopathic giant cell aortitis.
    Thorax, 1980, Volume: 35, Issue:1

    Topics: Adult; Aorta; Aortic Valve; Aortic Valve Insufficiency; Aortitis; Female; Giant Cell Arteritis; Hear

1980
Temporal arteritis in a black patient.
    Southern medical journal, 1980, Volume: 73, Issue:6

    Topics: Aged; Black People; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone

1980
Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness.
    JAMA, 1980, Oct-10, Volume: 244, Issue:15

    Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Prednisone; Recurrence; Temporal Arteries

1980
[Development of Horton's disease under corticotherapy].
    La Nouvelle presse medicale, 1980, Oct-11, Volume: 9, Issue:37

    Topics: Aged; Asthma; Cyclophosphamide; Female; Giant Cell Arteritis; Humans; Prednisone

1980
Prognosis and management of polymyalgia rheumatica.
    Annals of the rheumatic diseases, 1981, Volume: 40, Issue:1

    Topics: Giant Cell Arteritis; Humans; Nervous System Diseases; Polymyalgia Rheumatica; Prednisone; Prognosis

1981
Reversible perfusion disorder on brain SPECT after treatment with prednisone in temporal arteritis.
    Clinical nuclear medicine, 1995, Volume: 20, Issue:5

    Topics: Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Dementia, Vascular; Female; Giant Cell

1995
Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus.
    The Journal of rheumatology, 1993, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Adhesion Molecules; E-Selectin; Enzyme-Linked Immun

1993
Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman.
    The Journal of rheumatology, 1995, Volume: 22, Issue:2

    Topics: Adenocarcinoma; Female; Giant Cell Arteritis; Humans; Lung Neoplasms; Middle Aged; Prednisone

1995
Persisting temporal arteritis.
    Ophthalmology, 1995, Volume: 102, Issue:5

    Topics: Aged; Diplopia; Female; Giant Cell Arteritis; Headache; Humans; Ischemia; Optic Nerve; Prednisone; R

1995
Invasive aspergillosis. A complication of treatment of temporal arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1995, Volume: 15, Issue:1

    Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Brain; Fatal Outcome; Female; Giant C

1995
Ischemic optic neuropathy during corticosteroid therapy for giant cell arteritis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:6

    Topics: Administration, Oral; Aged; Female; Fundus Oculi; Giant Cell Arteritis; Humans; Ischemia; Optic Disk

1995
Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.
    Ophthalmology, 1994, Volume: 101, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Blindness; Female; Follow-Up Studies; Giant Cell Arte

1994
[Giant-cell arteritis. Comments on the case histories of 30 patients].
    Recenti progressi in medicina, 1994, Volume: 85, Issue:10

    Topics: Aged; Aged, 80 and over; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Midd

1994
Optic disc cupping in arteritic anterior ischemic optic neuropathy.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1994, Volume: 208, Issue:6

    Topics: Aged; Female; Fundus Oculi; Giant Cell Arteritis; Humans; Ischemia; Optic Disk; Optic Nerve; Optic N

1994
Pulmonary infarction caused by giant-cell arteritis of the pulmonary artery.
    The Netherlands journal of medicine, 1995, Volume: 46, Issue:1

    Topics: Aged; Female; Giant Cell Arteritis; Heparin; Humans; Prednisone; Pulmonary Artery; Pulmonary Embolis

1995
Severe anemia as the presenting manifestation of giant cell arteritis.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:3

    Topics: Aged; Anemia; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Prednisone

1995
Persistent giant cell arteritis despite corticosteroid treatment.
    Mayo Clinic proceedings, 1994, Volume: 69, Issue:11

    Topics: Aged; Aged, 80 and over; Giant Cell Arteritis; Humans; Male; Prednisone; Temporal Arteries; Time Fac

1994
Occult subacute thyroiditis mimicking classic giant cell arteritis.
    Arthritis and rheumatism, 1994, Volume: 37, Issue:11

    Topics: Diagnosis, Differential; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Propranolol; R

1994
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.
    Arthritis and rheumatism, 1994, Volume: 37, Issue:11

    Topics: Aged; Amyloidosis; Biopsy; Female; Giant Cell Arteritis; Humans; Intermittent Claudication; Male; Po

1994
"Recurrent" giant cell arteritis.
    Ophthalmology, 1994, Volume: 101, Issue:6

    Topics: Aged; Aged, 80 and over; Follow-Up Studies; Giant Cell Arteritis; Humans; Longitudinal Studies; Male

1994
[Potential risks of the withdrawal of corticoids in Horton's disease. Prospective study of 22 patients].
    La Revue de medecine interne, 1993, Volume: 14, Issue:10

    Topics: Adrenal Insufficiency; Aged; Giant Cell Arteritis; Humans; Hydrocortisone; Prednisone; Prospective S

1993
Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment.
    Archives of internal medicine, 1994, Jul-11, Volume: 154, Issue:13

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisone; Rifampin; Tuberculosis

1994
Temporal artery biopsy after one month of corticosteroid therapy.
    American journal of ophthalmology, 1994, Feb-15, Volume: 117, Issue:2

    Topics: Aged; Aged, 80 and over; Biopsy; Female; Giant Cell Arteritis; Humans; Prednisone; Temporal Arteries

1994
Production of interleukin 6 by granulomas of giant cell arteritis.
    Human immunology, 1994, Volume: 39, Issue:1

    Topics: Aged; Aged, 80 and over; Female; Gene Expression; Giant Cell Arteritis; Granuloma; Humans; In Situ H

1994
Multiple strokes after initiation of steroid therapy in giant cell arteritis.
    Postgraduate medical journal, 1994, Volume: 70, Issue:821

    Topics: Aged; Cerebral Infarction; Cerebrovascular Disorders; Female; Giant Cell Arteritis; Humans; Predniso

1994
How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?
    Annals of internal medicine, 1994, Jun-15, Volume: 120, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Biopsy; Chi-Square Distribution; Female; Gi

1994
[Giant cell arteritis and aortic dissection in 2 siblings].
    Schweizerische medizinische Wochenschrift, 1993, Oct-09, Volume: 123, Issue:40

    Topics: Aged; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; Female; Giant Cell A

1993
Polymyalgia rheumatica and giant cell arteritis in emergency department patients.
    Annals of emergency medicine, 1993, Volume: 22, Issue:10

    Topics: Aged; Emergencies; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone

1993
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.
    Arthritis and rheumatism, 1993, Volume: 36, Issue:9

    Topics: Aged; Base Sequence; Giant Cell Arteritis; Humans; Interleukin-6; Longitudinal Studies; Middle Aged;

1993
Simultaneous onset of giant cell arteritis and subacute thyroiditis.
    Annals of the rheumatic diseases, 1993, Volume: 52, Issue:11

    Topics: Aged; Aged, 80 and over; Female; Giant Cell Arteritis; Humans; Prednisone; Radionuclide Imaging; Thy

1993
[Immunohistochemical study of lesions of temporal arteritis in Horton's disease].
    Annales de medecine interne, 1993, Volume: 144, Issue:2

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Biopsy; Female; Giant Cell Arteritis; Humans; Immun

1993
Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
    British journal of rheumatology, 1993, Volume: 32, Issue:8

    Topics: Aged; Aged, 80 and over; CD4-CD8 Ratio; Female; Giant Cell Arteritis; Humans; Leukocyte Count; Lymph

1993
[Acute ischemia of the lower limb in a patient with temporal arteritis and rheumatoid arthritis, carrier of anticardiolipin antibodies].
    Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Arthritis, Rheumatoid; Blindness; Femor

1995
Giant cell arteritis of the breast.
    The Australian and New Zealand journal of surgery, 1996, Volume: 66, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Biopsy; Breast Diseases; Diagnosis, Differential; Female; Giant Cell

1996
Temporal arteritis: diagnostic and therapeutic considerations.
    The American surgeon, 1996, Volume: 62, Issue:6

    Topics: Aged; Axillary Artery; Biopsy; Blood Flow Velocity; Blood Sedimentation; Brachial Artery; Carotid Ar

1996
Low-dose corticosteroids and blindness in giant cell arteritis.
    British journal of rheumatology, 1996, Volume: 35, Issue:7

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Dose-Response Relationship, Drug; Giant Cell Arteritis; H

1996
Giant cell arteritis: diagnosis and management.
    Bulletin on the rheumatic diseases, 1996, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Hum

1996
In-office temporal artery biopsy.
    Rhode Island medicine, 1995, Volume: 78, Issue:12

    Topics: Aged; Aged, 80 and over; Ambulatory Care; Anti-Inflammatory Agents; Biopsy; Female; Giant Cell Arter

1995
Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticotherapy.
    The Journal of rheumatology, 1996, Volume: 23, Issue:2

    Topics: Aged; Aged, 80 and over; Cytokines; Female; Giant Cell Arteritis; Humans; Male; Prednisone; Prospect

1996
Intraoral lesion in giant cell arteritis.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1996, Volume: 82, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Mouth Diseases; Prednisone

1996
Serum soluble CD23 levels in giant cell arteritis.
    Immunology letters, 1996, Volume: 53, Issue:1

    Topics: Giant Cell Arteritis; Humans; Prednisone; Receptors, IgE; Solubility

1996
[The bane of giant cell arteritis from an ophthalmological viewpoint].
    Schweizerische medizinische Wochenschrift, 1996, Oct-26, Volume: 126, Issue:43

    Topics: Aged; Aged, 80 and over; Blindness; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis;

1996
[Neuropathy of the common peroneal nerve caused by giant cell arteritis].
    Minerva cardioangiologica, 1996, Volume: 44, Issue:11

    Topics: Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Male; Peripheral Nervous Syste

1996
Opportunistic infections in patients with temporal arteritis treated with corticosteroids.
    Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Bacteremia; Cryptococcosis; Fatal Outcome; Giant Cell Arteritis; Hum

1997
Large artery giant cell arteritis: a diagnosis to remember.
    Clinical rheumatology, 1997, Volume: 16, Issue:2

    Topics: Aged; Aged, 80 and over; Angiography; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroi

1997
Cotton-wool spots and the early diagnosis of giant cell arteritis.
    Ophthalmology, 1995, Volume: 102, Issue:11

    Topics: Aged; Biopsy; Female; Fluorescein Angiography; Fundus Oculi; Giant Cell Arteritis; Glucocorticoids;

1995
Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.
    British journal of rheumatology, 1997, Volume: 36, Issue:2

    Topics: Biopsy; Blindness; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methylprednisolone;

1997
Immunology and ocular manifestations of giant cell arteritis.
    Ocular immunology and inflammation, 1997, Volume: 5, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Fluorescein Angiography; Fundus Oculi; Giant Cell Arterit

1997
Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    The Journal of rheumatology, 1998, Volume: 25, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Female; Giant Ce

1998
Alternating amaurosis fugax and temporal arteritis.
    American journal of ophthalmology, 1997, Volume: 123, Issue:6

    Topics: Aged; Biopsy; Blindness; Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Humans; Mal

1997
Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1998, Volume: 18, Issue:2

    Topics: Aged; Anticoagulants; Basilar Artery; Cerebrovascular Disorders; Cranial Nerve Diseases; Diplopia; F

1998
Postural vision loss in giant cell arteritis.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1998, Volume: 18, Issue:2

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Hypotension, Orthostatic; Male; Methylprednisolone; Opti

1998
Facial pain and giant cell arteritis.
    The Journal of rheumatology, 1998, Volume: 25, Issue:6

    Topics: Aged; Facial Pain; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Intermittent Claudication;

1998
A 24-year-old man with symptoms and signs of polymyalgia rheumatica.
    The Journal of family practice, 1998, Volume: 47, Issue:1

    Topics: Adult; Blood Sedimentation; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administ

1998
Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
    Arthritis and rheumatism, 1998, Volume: 41, Issue:8

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Cerebrovascular Disorders; Female; Forecasting

1998
Pleural effusion as a form of presentation of temporal arteritis.
    British journal of rheumatology, 1998, Volume: 37, Issue:7

    Topics: Aged; Cough; Female; Giant Cell Arteritis; Humans; Pleural Effusion; Prednisone

1998
Positive temporal artery biopsy 6 months after prednisone treatment.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:9

    Topics: Aged; Biopsy; Blood Sedimentation; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone

1998
[Clinical thinking and decision making in the practice. A patient with fever of unknown origin].
    Nederlands tijdschrift voor geneeskunde, 1998, Jul-25, Volume: 142, Issue:30

    Topics: Aged; Anemia, Hypochromic; Biopsy; Blood Sedimentation; Female; Fever of Unknown Origin; Giant Cell

1998
Tongue necrosis in a patient with temporal arteritis.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1998, Volume: 56, Issue:10

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Male; Necrosis; Pre

1998
Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis.
    Annals of the rheumatic diseases, 1998, Volume: 57, Issue:6

    Topics: Aged; Aged, 80 and over; Alleles; Anti-Inflammatory Agents; Drug Resistance; Female; Follow-Up Studi

1998
Scalp necrosis with giant cell arteritis.
    Ophthalmology, 1998, Volume: 105, Issue:10

    Topics: Aged; Biopsy; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Infusi

1998
Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis.
    Muscle & nerve, 1999, Volume: 22, Issue:1

    Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Muscle Weakness

1999
Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.
    American journal of ophthalmology, 1999, Volume: 127, Issue:1

    Topics: Administration, Oral; Aged; Blindness; Disease Progression; Eye; Female; Giant Cell Arteritis; Human

1999
[Hepatic granulomas, giant-cell arteritis and miliary tuberculosis].
    Anales de medicina interna (Madrid, Spain : 1984), 1999, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Granuloma; Humans;

1999
Dysarthria associated with giant cell arteritis.
    The Journal of rheumatology, 1999, Volume: 26, Issue:4

    Topics: Aged; Arteries; Blood Sedimentation; Dysarthria; Giant Cell Arteritis; Humans; Larynx; Male; Prednis

1999
The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    The Journal of rheumatology, 1999, Volume: 26, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Follow-Up Studies; Giant

1999
Unilateral proptosis resulting from giant-cell arteritis.
    Journal of the American Optometric Association, 1999, Volume: 70, Issue:7

    Topics: Administration, Oral; Aged; Chronic Disease; Disease Progression; Exophthalmos; Follow-Up Studies; G

1999
[Rhizomelic pseudopolyarthritis: diagnosis, course, treatment].
    La Revue du praticien, 1999, May-15, Volume: 49, Issue:10

    Topics: Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials;

1999
Giant-cell arteritis presenting as an orbital pseudotumor.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:4

    Topics: Aged; Diagnosis, Differential; Female; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Hum

1999
Arteritis of the temporal and subclavian artery.
    Vascular medicine (London, England), 2000, Volume: 5, Issue:2

    Topics: Aged; Arteritis; Female; Giant Cell Arteritis; Humans; Prednisone; Subclavian Artery; Ultrasonograph

2000
What is the appropriate initial dose of corticosteroids to treat giant cell arteritis?
    Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:8

    Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone

2000
The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    The Journal of rheumatology, 2000, Volume: 27, Issue:9

    Topics: Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheuma

2000
Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases.
    Rheumatology (Oxford, England), 2000, Volume: 39, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Biopsy; Drug Therapy, Combination; Fema

2000
Giant cell arteritis. Episodes of syncope add complexity to an unusual presentation.
    Geriatrics, 2000, Volume: 55, Issue:11

    Topics: Aged; Anti-Inflammatory Agents; Biopsy; Confusion; Diagnosis, Differential; Female; Giant Cell Arter

2000
[Horton's disease and hypereosinophilic syndrome: a non-fortuitous association].
    Annales de medecine interne, 2000, Volume: 151, Issue:7

    Topics: Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Hydroxyurea;

2000
Painful chewing and blindness: signs and symptoms of temporal arteritis.
    Journal of the American Dental Association (1939), 2000, Volume: 131, Issue:12

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Diplopia; Facial Pain; Giant Cell Arteritis; Headache; Hu

2000
Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
    Arthritis and rheumatism, 2001, Volume: 45, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Mid

2001
Giant cell arteritis and secondary amyloidosis: the natural history.
    Scandinavian journal of rheumatology, 2001, Volume: 30, Issue:2

    Topics: Aged; Amyloid; Amyloidosis; Fatal Outcome; Fever of Unknown Origin; Giant Cell Arteritis; Humans; Ma

2001
[Horton's disease in elderly patients aged over 75: clinical course, complications of corticotherapy. Comparative study of 164 patients. Towards a reduced initial dose].
    La Revue de medecine interne, 2001, Volume: 22, Issue:7

    Topics: Age Factors; Aged; Anti-Inflammatory Agents; Biopsy; Disease Progression; Drug Administration Schedu

2001
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.
    The American journal of medicine, 2001, Aug-15, Volume: 111, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Female; Giant Cell Arteritis; Humans; Mal

2001
[Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients].
    La Revue de medecine interne, 2001, Volume: 22, Issue:11

    Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Female; Giant Cell Arteritis; Gluc

2001
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis.
    Arthritis and rheumatism, 2002, Volume: 47, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Female; Giant C

2002
Aching alopecia.
    Lancet (London, England), 2002, Apr-06, Volume: 359, Issue:9313

    Topics: Aged; Alopecia; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisone

2002
Temporal arteritis: a cough, toothache, and tongue infarction.
    JAMA, 2002, Jun-12, Volume: 287, Issue:22

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Blood Sedimentation; Cough; Female; Giant Cell Arteritis;

2002
Audit of the management of suspected giant cell arteritis in a large teaching hospital.
    Internal medicine journal, 2002, Volume: 32, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Giant Ce

2002
Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases.
    Scandinavian journal of rheumatology, 1979, Volume: 8, Issue:3

    Topics: Adult; Aged; Arthritis, Rheumatoid; Capillary Permeability; Dermatomyositis; Giant Cell Arteritis; H

1979
[Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica].
    Ugeskrift for laeger, 1977, Oct-31, Volume: 139, Issue:44

    Topics: Aged; Azathioprine; Back Pain; Drug Evaluation; Drug Therapy, Combination; Female; Fractures, Sponta

1977
Unusual electromyographic findings in a patient with polymyalgia rheumatica.
    Arthritis and rheumatism, 1979, Volume: 22, Issue:3

    Topics: Creatine Kinase; Electromyography; Female; Fructose-Bisphosphate Aldolase; Giant Cell Arteritis; Hum

1979
Temporal arteritis--progressive affection of vision during high-level corticosteroid therapy. A case report.
    Acta medica Scandinavica, 1979, Volume: 205, Issue:5

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Prednisone; Vision Disorders

1979
[Temporal arteritis. Loss of vision during corticosteroid therapy].
    Ugeskrift for laeger, 1979, Jun-25, Volume: 141, Issue:26

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Prednisone; Vision Disorders

1979
Ocular complications of temporal arteritis.
    British medical journal, 1979, Jun-02, Volume: 1, Issue:6176

    Topics: Eye Diseases; Giant Cell Arteritis; Humans; Middle Aged; Prednisone

1979
Intracranial involvement of giant-cell arteritis.
    Neurology, 1977, Volume: 27, Issue:8

    Topics: Cerebral Arterial Diseases; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Radiography

1977
Bone changes during prednisone treatment.
    Acta medica Scandinavica, 1977, Volume: 202, Issue:4

    Topics: Aged; Bone and Bones; Drug Evaluation; Female; Giant Cell Arteritis; Humans; Hydroxyproline; Leukemi

1977
Reversible mental symptoms in temporal arteritis.
    The Journal of nervous and mental disease, 1978, Volume: 166, Issue:6

    Topics: Aged; Attention; Giant Cell Arteritis; Humans; Male; Memory Disorders; Mental Recall; Prednisone

1978
Giant cell arteritis with scalp necrosis.
    International journal of dermatology, 1978, Volume: 17, Issue:8

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Necrosis; Prednisone; Scalp; Skin Ulcer; Vision Disorders

1978
Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.
    Annals of the rheumatic diseases, 1977, Volume: 36, Issue:1

    Topics: Aged; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone

1977
Angiographic findings in giant cell arteritis.
    Southern medical journal, 1977, Volume: 70, Issue:8

    Topics: Aged; Angiography; Blindness; Carotid Arteries; Female; Giant Cell Arteritis; Humans; Prednisone; Te

1977
Giant cell arteritis and blindness.
    American family physician, 1977, Volume: 16, Issue:3

    Topics: Aged; Blindness; Carotid Artery Diseases; Diagnosis, Differential; Giant Cell Arteritis; Humans; Mid

1977
Active giant cell arteritis with cerebral involvement. Findings following four years of corticosteroid therapy.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1976, Volume: 94, Issue:12

    Topics: Aged; Blood Sedimentation; Female; Giant Cell Arteritis; Glaucoma; Humans; Meningoencephalitis; Pred

1976
Complications of corticosteroid therapy in presumptive temporal arteritis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1976, Volume: 11, Issue:2

    Topics: Aged; Autopsy; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Opportunistic Infections; Prednis

1976
Editorial: alternate-day prednisone therapy.
    Annals of internal medicine, 1975, Volume: 82, Issue:5

    Topics: Giant Cell Arteritis; Humans; Prednisone

1975
[Temporal arteritis (author's transl)].
    Revista medica de Chile, 1975, Volume: 103, Issue:6

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; Prednisone

1975
Diseases of the central nervous system. Relief of pain: headache, facial neuralgia, migraine, and phantom limb.
    British medical journal, 1975, Oct-11, Volume: 4, Issue:5988

    Topics: Analgesics; Aspirin; Carbamazepine; Ergotamines; Facial Neuralgia; Giant Cell Arteritis; Headache; H

1975
[Neurologic aspects of cranial arteritis].
    Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie, 1975, Volume: 117, Issue:2

    Topics: Aged; Female; Giant Cell Arteritis; Headache; Humans; Male; Middle Aged; Neurologic Manifestations;

1975
Acute transient ophthalmomalacia in giant-cell arteritis. Report of a case.
    Acta ophthalmologica, 1975, Volume: 53, Issue:6

    Topics: Acute Disease; Aged; Ciliary Body; Corneal Diseases; Edema; Female; Giant Cell Arteritis; Humans; Pr

1975
[Rheumatic polymyalgia--temporal arteritis. Temporary remission without glucocorticoid therapy].
    Ugeskrift for laeger, 1976, Jan-12, Volume: 138, Issue:3

    Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; Remission, S

1976
Arteritis of the aged (giant cell arteritis) and fever of unexplained origin.
    The American journal of medicine, 1976, Volume: 60, Issue:3

    Topics: Aged; Anemia; Blood Sedimentation; Diagnosis, Differential; Female; Fever of Unknown Origin; Giant C

1976
[Anti-cardiolipin antibodies in Horton's disease].
    Annales de medecine interne, 1992, Volume: 143, Issue:7

    Topics: Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Blood Proteins; Female; Giant Cell Arteritis;

1992
[Horton's bitemporal arteritis. A case report].
    Recenti progressi in medicina, 1992, Volume: 83, Issue:10

    Topics: Aged; Biopsy; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Levodopa; Prednisone;

1992
[Temporal arteritis without histological changes].
    Ugeskrift for laeger, 1992, Oct-19, Volume: 154, Issue:43

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Papilledema; Prednisone; Vision Disorders

1992
Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    The Journal of rheumatology, 1992, Volume: 19, Issue:7

    Topics: Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Mal

1992
[Immunosuppressor treatment in temporal arteritis of long-term evolution].
    Anales de medicina interna (Madrid, Spain : 1984), 1992, Volume: 9, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Female; Giant Cell Art

1992
Diagnosing giant cell temporal arteritis.
    The West Virginia medical journal, 1992, Volume: 88, Issue:5

    Topics: Aged; Angiography; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Temp

1992
[Temporal arteritis with involvement of the subclavian arteries].
    Revista clinica espanola, 1992, Volume: 190, Issue:8

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisone; Radiography; Recurrence; Subclavian Artery

1992
Transient monocular blindness in a patient with giant-cell arteritis. Pathogenetic and therapeutic considerations.
    Recenti progressi in medicina, 1992, Volume: 83, Issue:4

    Topics: Acute Disease; Aged; Blindness; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Male; Nitro

1992
Giant cell arteritis and polymyalgia rheumatica.
    Hospital practice (Office ed.), 1992, Jan-15, Volume: 27, Issue:1

    Topics: Aged; Algorithms; Biopsy; Blood Sedimentation; Clinical Protocols; Decision Trees; Diagnosis, Differ

1992
[Severe late complication of Horton's disease occurring during treatment].
    Presse medicale (Paris, France : 1983), 1991, Feb-09, Volume: 20, Issue:5

    Topics: Aged; Cerebral Infarction; Giant Cell Arteritis; Humans; Male; Prednisone

1991
Kaposi's sarcoma in a patient with temporal arteritis treated with corticosteroid.
    Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:6 Pt 1

    Topics: Female; Giant Cell Arteritis; Humans; Middle Aged; Prednisone; Sarcoma, Kaposi; Skin Neoplasms

1991
[Giant cell arteritis: more than just temporal arteritis].
    Nederlands tijdschrift voor geneeskunde, 1991, Jan-12, Volume: 135, Issue:2

    Topics: Aged; Aorta; Coronary Vessels; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone;

1991
Pneumocystis carinii pneumonia following corticosteroid therapy for giant cell arteritis.
    Wisconsin medical journal, 1991, Volume: 90, Issue:4

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Pneumonia, Pneumocystis; Prednisone

1991
[Giant-cell temporal arteritis: clinico-diagnostic and therapeutic aspects].
    Giornale di clinica medica, 1990, Volume: 71, Issue:12

    Topics: Adult; Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Prognosis

1990
Temporal arteritis.
    Compendium (Newtown, Pa.), 1990, Volume: 11, Issue:10

    Topics: Aged; Biopsy; Blindness; Blood Sedimentation; Female; Giant Cell Arteritis; Headache; Humans; Male;

1990
[Inflammation proteins in Horton's disease. Prospective study of 25 patients].
    Annales de medecine interne, 1990, Volume: 141, Issue:4

    Topics: Aged; Aged, 80 and over; Blood Proteins; Blood Sedimentation; Female; Giant Cell Arteritis; Humans;

1990
[Hutchinson-Horton ulcero-necrotizing cranial arteritis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1990, Volume: 41, Issue:10

    Topics: Aged; Aged, 80 and over; Female; Giant Cell Arteritis; Humans; Necrosis; Prednisone; Scalp

1990
Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica.
    The American journal of medicine, 1990, Volume: 88, Issue:1

    Topics: Aged; Arm; Axillary Artery; Female; Giant Cell Arteritis; Humans; Ischemia; Middle Aged; Polymyalgia

1990
Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management.
    Eye (London, England), 1990, Volume: 4 ( Pt 1)

    Topics: Blindness; Blood Sedimentation; C-Reactive Protein; Diagnosis, Differential; Fluorescein Angiography

1990
Temporal arteritis with normal erythrocyte sedimentation rate.
    Journal of internal medicine, 1990, Volume: 227, Issue:4

    Topics: Aged; Blood Sedimentation; Diagnostic Errors; Female; Giant Cell Arteritis; Humans; Prednisone; Temp

1990
Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia.
    Neurology, 1990, Volume: 40, Issue:5

    Topics: Aged; Aged, 80 and over; Biopsy; Cerebral Arteries; Dementia, Multi-Infarct; Female; Giant Cell Arte

1990
[Polymyalgia rheumatica and temporal arteritis. Observations on prognosis and treatment].
    Bulletin de l'Academie nationale de medecine, 1990, Volume: 174, Issue:2

    Topics: Biopsy; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone; Prognosis

1990
Change of serum calcitonin in patients receiving glucocorticoids: an acute phase study.
    The Netherlands journal of medicine, 1990, Volume: 36, Issue:5-6

    Topics: Acute Disease; Aged; Calcitonin; Calcium; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; O

1990
Lower extremity peripheral neuropathy and ischemic ulcers associated with giant cell arteritis.
    The Journal of rheumatology, 1989, Volume: 16, Issue:10

    Topics: Foot Diseases; Giant Cell Arteritis; Headache; Humans; Leg; Male; Middle Aged; Peripheral Nervous Sy

1989
Giant cell arteritis: loss of vision during corticosteroid therapy.
    Journal of internal medicine, 1989, Volume: 225, Issue:3

    Topics: Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Vision Disorders; Visual Acuity

1989
Corticosteroid dosage for temporal arteritis.
    Annals of the rheumatic diseases, 1989, Volume: 48, Issue:4

    Topics: Adrenal Cortex Hormones; Giant Cell Arteritis; Humans; Prednisone

1989
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.
    Cleveland Clinic journal of medicine, 1989, Volume: 56, Issue:3

    Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Ag

1989
Internuclear ophthalmoplegia in giant cell arteritis.
    The Journal of rheumatology, 1989, Volume: 16, Issue:5

    Topics: Aged; Diplopia; Giant Cell Arteritis; Humans; Male; Middle Aged; Ophthalmoplegia; Prednisone; Saccad

1989
[Giant cell arteritis].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1989, Dec-01, Volume: 41, Issue:23

    Topics: Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methylprednisolone; Middle Aged; Pr

1989
Temporal arteritis and intestinal perforation. Report of three cases.
    New York state journal of medicine, 1989, Volume: 89, Issue:8

    Topics: Aged; Colonic Diseases; Duodenal Ulcer; Female; Giant Cell Arteritis; Humans; Intestinal Fistula; In

1989
Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.
    Arthritis and rheumatism, 1989, Volume: 32, Issue:7

    Topics: Antibodies, Monoclonal; Antigens, Differentiation; Dendritic Cells; Giant Cell Arteritis; HLA-DR Ant

1989
Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly.
    Arthritis and rheumatism, 1989, Volume: 32, Issue:10

    Topics: Aged; Dementia; Giant Cell Arteritis; Humans; Male; Memory Disorders; Prednisone

1989
[Cure of diabetes by corticotherapy in Horton's disease].
    Presse medicale (Paris, France : 1983), 1985, Dec-07, Volume: 14, Issue:42

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Hyperglycemia; Prednisone

1985
[Prognosis of treated temporal arteritis. Retrospective study of 87 cases].
    Presse medicale (Paris, France : 1983), 1986, Mar-29, Volume: 15, Issue:13

    Topics: Aged; Chloroquine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Giant Cell Arteriti

1986
[Flaccid paraplegia of abrupt onset. Complication of corticoid treatment of Horton's disease?].
    Presse medicale (Paris, France : 1983), 1986, May-03, Volume: 15, Issue:18

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Muscle Hypotonia; Paraplegia; Prednisone

1986
Bilateral sixth nerve pareses with temporal arteritis and diabetes.
    Journal of clinical neuro-ophthalmology, 1986, Volume: 6, Issue:2

    Topics: Abducens Nerve; Aged; Benzothiadiazines; Blindness; Diabetes Mellitus, Type 2; Diuretics; Female; Gi

1986
Diagnosis of polymyalgia rheumatica and giant cell arteritis: a note of caution.
    Israel journal of medical sciences, 1987, Volume: 23, Issue:12

    Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Lymphoma; Male; Middle Aged; Mu

1987
Prolonged corticosteroid treatment in the management of temporal arteritis.
    Klinische Wochenschrift, 1988, Dec-01, Volume: 66, Issue:23

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Long-Term Care; Male; Prednisone; Temporal Arteries

1988
Decreased level of suppressor/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity.
    The Journal of rheumatology, 1985, Volume: 12, Issue:2

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Leukocyte Count; Male; Middle Aged; Polymyalgia Rheumati

1985
Temporal arteritis.
    The West Virginia medical journal, 1988, Volume: 84, Issue:11

    Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Prednisone

1988
Arm ischemia secondary to giant cell arteritis.
    Annals of vascular surgery, 1988, Volume: 2, Issue:4

    Topics: Arm; Brachial Artery; Carotid Arteries; Combined Modality Therapy; Giant Cell Arteritis; Graft Occlu

1988
Diagnostic value of the history and examination in giant cell arteritis: a clinical pathological study of 81 temporal artery biopsies.
    The Journal of rheumatology, 1988, Volume: 15, Issue:12

    Topics: Aged; Aged, 80 and over; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Midd

1988
Temporal arteritis: clinical aids to diagnosis.
    The Journal of rheumatology, 1988, Volume: 15, Issue:12

    Topics: Aged; Aged, 80 and over; Algorithms; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans

1988
Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes.
    The Journal of rheumatology, 1987, Volume: 14, Issue:4

    Topics: Adult; Aged; Dermatomyositis; Diabetes Mellitus, Type 1; Female; Giant Cell Arteritis; Humans; Insul

1987
[A case of giant-cell arteritis].
    Terapevticheskii arkhiv, 1988, Volume: 60, Issue:4

    Topics: Aged; Giant Cell Arteritis; Humans; Male; Prednisone; Temporal Arteries

1988
Giant cell arteritis of the tongue presenting as macroglossia.
    The Journal of rheumatology, 1988, Volume: 15, Issue:6

    Topics: Deglutition Disorders; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Macroglossia;

1988
[Temporal arteritis. Reduced vision during steroid treatment].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1987, Mar-30, Volume: 107, Issue:9

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisone; Vision Disorders

1987
Sudden deafness in a patient with temporal arteritis.
    The Journal of rheumatology, 1987, Volume: 14, Issue:2

    Topics: Aged; Audiometry; Female; Giant Cell Arteritis; Hearing Loss, Sudden; Humans; Prednisone

1987
Giant cell arteritis causes recurrent posterior circulation transient ischemic attacks which respond to corticosteroid.
    European neurology, 1987, Volume: 27, Issue:2

    Topics: Aged; Giant Cell Arteritis; Humans; Ischemic Attack, Transient; Male; Prednisone; Recurrence

1987
Polymyalgia rheumatica and temporal arteritis: managing older patients.
    Geriatrics, 1986, Volume: 41, Issue:6

    Topics: Aged; Biopsy; Blood Sedimentation; Diagnosis, Differential; Giant Cell Arteritis; Humans; Polymyalgi

1986
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1986. A 65-year-old woman with bilateral pulmonary infiltrates.
    The New England journal of medicine, 1986, Jun-19, Volume: 314, Issue:25

    Topics: Aged; Biopsy; Bronchi; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Lung; Pneumoni

1986
Polymyalgia rheumatica.
    British journal of hospital medicine, 1986, Volume: 36, Issue:3

    Topics: Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica

1986
Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica.
    Archives of internal medicine, 1986, Volume: 146, Issue:11

    Topics: Aged; Alkaline Phosphatase; Blood Sedimentation; Female; Giant Cell Arteritis; Hematocrit; Humans; P

1986
Kaposi's sarcoma following corticosteroid treatment for temporal arteritis--a case report.
    Angiology, 1987, Volume: 38, Issue:1 Pt 1

    Topics: Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Sarcoma, Kaposi; Skin Neoplasms

1987
Ischaemia of the tongue due to temporal arteritis.
    The New Zealand medical journal, 1985, Feb-13, Volume: 98, Issue:772

    Topics: Aged; Giant Cell Arteritis; Humans; Ischemia; Male; Prednisone; Tongue

1985
Large intracranial arteritis with giant cells in systemic lupus erythematosus.
    Annals of internal medicine, 1986, Volume: 104, Issue:5

    Topics: Adult; Cerebral Arterial Diseases; Cerebral Infarction; Female; Giant Cell Arteritis; Headache; Huma

1986
Polymyalgia rheumatica and giant cell arteritis. The dilemma of therapy.
    Postgraduate medicine, 1985, Volume: 77, Issue:8

    Topics: Aged; Blindness; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; P

1985
Aortic regurgitation in giant cell arteritis.
    Arthritis and rheumatism, 1985, Volume: 28, Issue:5

    Topics: Aged; Aortic Aneurysm; Aortic Valve Insufficiency; Female; Giant Cell Arteritis; Humans; Prednisone

1985
[Giant cell arteritis. Multicenter study of 100 cases with positive biopsies].
    Medicina clinica, 1985, Jun-08, Volume: 85, Issue:2

    Topics: Aged; Biopsy; Blindness; Female; Giant Cell Arteritis; Headache; Humans; Male; Middle Aged; Myositis

1985
Cyclosporine: a new adjuvant therapy for giant cell arteritis?
    Arthritis and rheumatism, 1985, Volume: 28, Issue:9

    Topics: Adjuvants, Pharmaceutic; Aged; Cyclosporins; Female; Giant Cell Arteritis; Humans; Male; Prednisone

1985
Gradual loss and recovery of vision in temporal arteritis.
    Archives of internal medicine, 1985, Volume: 145, Issue:12

    Topics: Aged; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Prednisone; Time Factors; Vision Di

1985
Observations on temporal arteritis.
    Acta medica Scandinavica, 1972, Volume: 192, Issue:5

    Topics: Aged; Alkaline Phosphatase; Alpha-Globulins; Biopsy; Blindness; Blood Protein Disorders; Blood Prote

1972
[Polymyalgia rheumatica and its treatment].
    Deutsche medizinische Wochenschrift (1946), 1974, Sep-06, Volume: 99, Issue:36

    Topics: Alpha-Globulins; Arteritis; Biopsy; Blindness; Blood Sedimentation; Collagen Diseases; Giant Cell Ar

1974
Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
    Lancet (London, England), 1967, Mar-18, Volume: 1, Issue:7490

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Poly

1967
Early symptoms of temporal arteritis.
    Lancet (London, England), 1967, Sep-23, Volume: 2, Issue:7517

    Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia

1967
Giant-cell arteritis with peripheral neuropathy.
    Lancet (London, England), 1968, May-11, Volume: 1, Issue:7550

    Topics: Aged; Anemia, Hypochromic; Biopsy; Diagnosis, Differential; Giant Cell Arteritis; Humans; Iron; Male

1968
Renal vascular involvement in a case of polymyalgia rheumatica with temporal arteritis. A study of successive biopsies.
    Acta medica Scandinavica, 1969, Volume: 185, Issue:5

    Topics: Aged; Biopsy; Blood Protein Electrophoresis; Blood Sedimentation; Female; gamma-Globulins; Giant Cel

1969
Histopathology of ischemic optic neuropathy.
    American journal of ophthalmology, 1970, Volume: 69, Issue:1

    Topics: Aged; Arteries; Blindness; Ciliary Body; Female; Giant Cell Arteritis; Humans; Ischemia; Nerve Degen

1970
Giant cell arteritis--the need for prolonged treatment.
    Journal of chronic diseases, 1973, Volume: 26, Issue:9

    Topics: Age Factors; Aged; Betamethasone; Biopsy; Blindness; Chronic Disease; Female; Giant Cell Arteritis;

1973
[Arterial involvements in Horton's disease].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1969, Feb-08, Volume: 45, Issue:7

    Topics: Aortography; Arteritis; Arthritis; Biopsy; Femoral Artery; Giant Cell Arteritis; Headache; Humans; H

1969
[Etiopathogenetic considerations on temporal arteritis].
    Minerva medica, 1967, Sep-29, Volume: 58, Issue:78

    Topics: Arteritis; Brachial Artery; Collagen Diseases; Giant Cell Arteritis; Humans; Male; Middle Aged; Poly

1967
[Nearly blind--due to temporal arteritis].
    Nederlands tijdschrift voor geneeskunde, 1969, Jan-04, Volume: 113, Issue:1

    Topics: Aged; Blindness; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Middle Aged; Polyart

1969
Temporal arteritis heralded by facial nerve palsy.
    JAMA, 1974, May-13, Volume: 228, Issue:7

    Topics: Aged; Anorexia Nervosa; Biopsy; Facial Paralysis; Female; Fundus Oculi; Giant Cell Arteritis; Humans

1974
[Temporal arteritis--inflammatory vascular disease of the higher age].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1974, Dec-01, Volume: 29, Issue:23

    Topics: Age Factors; Aged; Anticoagulants; Azathioprine; Blindness; Female; Giant Cell Arteritis; Humans; Pr

1974
Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.
    Annals of internal medicine, 1972, Volume: 77, Issue:6

    Topics: Age Factors; Aged; Biopsy; Diagnosis, Differential; Eye Manifestations; Female; Giant Cell Arteritis

1972
Giant-cell arteritis: ophthalmic and systemic considerations.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1973, Volume: 8, Issue:1

    Topics: Age Factors; Aged; Arterial Occlusive Diseases; Arteritis; Biopsy; Blindness; Blood Sedimentation; D

1973
Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function.
    JAMA, 1973, Jun-11, Volume: 224, Issue:11

    Topics: Aged; Aortography; Arteritis; Biopsy; Female; Giant Cell Arteritis; Humans; Liver; Male; Middle Aged

1973
Temporal arteritis, steroid therapy, and pulmonary emboli.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1973, Volume: 90, Issue:5

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Prednisone; Pulmonary Embolism

1973
Polymyalgia rheumatica: a review of recent literature.
    The Ohio State medical journal, 1973, Volume: 69, Issue:9

    Topics: Adult; Age Factors; Aged; Biopsy; Cortisone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged

1973
[Case of Horton's disease (arteritis temporalis)].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1973, Aug-15, Volume: 26, Issue:16

    Topics: Aged; Diabetes Complications; Giant Cell Arteritis; Humans; Male; Prednisone

1973
[Temporal arteritis].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Apr-10, Volume: 93, Issue:10

    Topics: Aged; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone

1973
[Letter: Temporal arteritis].
    Deutsche medizinische Wochenschrift (1946), 1973, Nov-02, Volume: 98, Issue:44

    Topics: Giant Cell Arteritis; Humans; Prednisolone; Prednisone; Recurrence

1973
[Polymyalgia rheumatica].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Nov-20, Volume: 93, Issue:32

    Topics: Biopsy; Diagnosis, Differential; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; S

1973
Thyrotoxicosis and giant-cell arteritis.
    British medical journal, 1974, May-25, Volume: 2, Issue:5916

    Topics: Aged; Autoimmune Diseases; Biopsy; Female; Giant Cell Arteritis; Hematocrit; Humans; Hyperthyroidism

1974
Temporal arteritis.
    Postgraduate medicine, 1974, Volume: 56, Issue:3

    Topics: Age Factors; Aged; Angiography; Biopsy; Blindness; Blood Proteins; Blood Sedimentation; Carotid Arte

1974
[Clinical observations in patients with giant cell arteritis, temporal arteritis].
    Die Medizinische Welt, 1972, Apr-22, Volume: 23, Issue:17

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone

1972
[Aortic arch syndrome caused by inflammatory vascular diseases].
    Deutsche medizinische Wochenschrift (1946), 1972, Sep-15, Volume: 97, Issue:37

    Topics: Aged; Angiography; Aortic Arch Syndromes; Aortography; Arteritis; Autopsy; Axillary Artery; Blood Pr

1972
[Temporal arteritis with involvement of the salivary glands].
    Arquivos de neuro-psiquiatria, 1972, Volume: 30, Issue:3

    Topics: Depression; Giant Cell Arteritis; Headache; Humans; Male; Middle Aged; Prednisone; Salivary Gland Di

1972
Giant cell arteritis (temporal arteritis).
    Transactions of the American Neurological Association, 1971, Volume: 96

    Topics: Aged; Blindness; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisone; Vision Disorde

1971
[Temporal arteritis].
    Lijecnicki vjesnik, 1970, Volume: 92, Issue:3

    Topics: Aged; Giant Cell Arteritis; Humans; Indomethacin; Male; Prednisone

1970
Polymyalgia rheumatica.
    Bulletin on the rheumatic diseases, 1969, Volume: 20, Issue:3

    Topics: Aged; Arteritis; Blood Sedimentation; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumat

1969
Occult temporal arteritis.
    JAMA, 1970, Aug-17, Volume: 213, Issue:7

    Topics: Aged; Blindness; Female; Giant Cell Arteritis; Humans; Optic Atrophy; Papilledema; Prednisone

1970
[Acute yellow atrophy of the liver following Australia antigen-positive transfusion].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1970, Nov-15, Volume: 90, Issue:22

    Topics: Acute Disease; Aged; Antigens; Atrophy; Female; Gastrectomy; Giant Cell Arteritis; Hepatitis B virus

1970
[Papillitis due to vascular diseases].
    Zeitschrift fur arztliche Fortbildung, 1970, Dec-15, Volume: 64, Issue:24

    Topics: Aged; Arteriosclerosis Obliterans; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; In

1970
[Differential diagnosis and therapy of temporal arteritis].
    Zeitschrift fur arztliche Fortbildung, 1970, Volume: 64, Issue:15

    Topics: Aged; Biopsy; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Prednisone

1970
Recurrent blanching of the tongue due to giant cell arteritis.
    Annals of internal medicine, 1968, Volume: 69, Issue:4

    Topics: Aged; Coronary Disease; Female; Gangrene; Giant Cell Arteritis; Humans; Prednisone; Tongue; Tongue D

1968
["Supraclavicular padding" as symptom of giant cell arteritis (arteriitis temporalis)].
    Schweizerische medizinische Wochenschrift, 1968, Oct-26, Volume: 98, Issue:43

    Topics: Aged; Diagnosis, Differential; Edema; Giant Cell Arteritis; Humans; Inflammation; Male; Neck; Predni

1968
Giant cell arteritis with polymyalgia rheumatica, loss of vision, and abdominal symptoms occurring during a four year course.
    Arthritis and rheumatism, 1969, Volume: 12, Issue:2

    Topics: Aged; Blindness; Blood Sedimentation; Diarrhea; Gastrointestinal Diseases; Giant Cell Arteritis; Hum

1969
[Chronic idiopathic dysproteinemia as an early symptom of temporal arteritis].
    Casopis lekaru ceskych, 1969, Sep-26, Volume: 108, Issue:40

    Topics: Aged; Blood Protein Disorders; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia

1969
Polymyalgia rheumatica and its relation to arteritis temporalis.
    Acta medica Scandinavica, 1965, Volume: 178, Issue:5

    Topics: Aged; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Midd

1965
The recognition and importance of cranial arteritis.
    The Medical journal of Australia, 1966, Jan-15, Volume: 1, Issue:3

    Topics: Blindness; Female; Giant Cell Arteritis; Headache; Humans; Male; Prednisolone; Prednisone; Vascular

1966
Gangrene of the tongue caused by temporal arteritis.
    The Medical journal of Australia, 1966, Sep-03, Volume: 2, Issue:10

    Topics: Aged; Biopsy; Blood; Female; Gangrene; Giant Cell Arteritis; Humans; Leukoplakia; Prednisone; Tongue

1966